This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
C3_FEMALE_GENITAL_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
7494 |
6. Filter based on genotype QC (FinnGen only) |
7494 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 7494 | 7494 | - |
| Unadjusted period prevalence (%) | 2.55 | 2.55 | - |
| Median age at first event (years) | 62.78 | 62.78 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 5421
- Matched controls
- 54085
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
WF003
NOMESCO Finland
Adjuvant radiotherapy
1286.4
323.0
678
6
ZXC96
NOMESCO Finland
Robot assisted procedure
59.5
323.0
619
117
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
323.0
2305
*
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
+∞
323.0
645
*
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
13.1
323.0
1107
1036
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
323.0
415
*
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
16.0
323.0
1787
1615
B01AB10
ATC
tinzaparin; parenteral
18.9
323.0
1614
1187
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
323.0
313
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
11.7
323.0
655
630
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
323.0
451
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
323.0
461
*
A04AA02
ATC
granisetron; systemic, transdermal
241.4
323.0
505
23
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
67.9
323.0
392
62
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
323.0
318
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
998.6
323.0
459
5
JN4AD
NOMESCO Finland
Body CT examination
15.1
323.0
896
699
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
6.9
323.0
1629
3175
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.4
323.0
2995
11870
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
323.0
838
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
541.2
323.0
670
14
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
36.1
323.0
1035
351
128
Kela drug reimbursment
Cancers of female genital organs
4503599627370496.0
323.0
2125
*
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
+∞
323.0
431
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
1861.9
323.0
491
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
23.5
323.0
772
379
A04AA01
ATC
ondansetron; systemic, rectal
27.1
323.0
1327
639
H02AB02
ATC
dexamethasone; systemic
100.4
323.0
1728
251
115
Kela drug reimbursment
Breast cancer
+∞
323.0
386
*
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
1269.8
323.0
466
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
233.2
323.0
350
16
Z51.5
ICD-10 Finland
Palliative care
17.2
323.0
685
451
N95.0
ICD-10 Finland
Postmenopausal bleeding
5.2
323.0
1608
4066
L02BG04
ATC
letrozole; oral
52.5
323.0
583
124
A03FA01
ATC
metoclopramide; systemic, rectal
8.6
323.0
2420
4652
JAL30
NOMESCO Finland
Omentectomy
124.6
323.0
790
74
PJA12
NOMESCO Finland
Sentinel node biopsy
498.3
323.0
460
10
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
1115.5
323.0
598
6
JN4BD
NOMESCO Finland
Extensive body CT
18.4
323.0
1506
1106
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.8
323.0
2356
9097
XX3DW
NOMESCO Finland
Time consuming IT work
9.4
323.0
927
1160
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
323.0
1587
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
19.6
323.0
796
470
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.0
323.0
872
1437
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
323.0
942
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
10278.0
323.0
878
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
2613.2
323.0
499
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
4567.9
323.0
433
*
L03AA13
ATC
pegfilgrastim; parenteral
3751.5
323.0
683
*
B01AB05
ATC
enoxaparin; parenteral
4.4
323.0
2911
11268
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
5.8
323.0
1731
4072
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
20.4
323.0
1151
706
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1363.0
323.0
713
6
LCD00
NOMESCO Finland
Hysterectomy
7.7
323.0
1101
1738
L03AA02
ATC
filgrastim; parenteral
215.4
315.6
325
16
130
Kela drug reimbursment
Malignant tumour
+∞
312.3
297
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
1627.0
311.9
301
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
334.3
311.2
313
10
WF049
NOMESCO Finland
Radiotherapy of metastasis
2975.8
305.6
293
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
291.0
277
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
10.8
290.2
586
598
JEA00
NOMESCO Finland
Appendectomy
7.0
290.0
773
1249
C54.1
ICD-10 Finland
Malignant neoplasm: Endometrium
+∞
287.8
274
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
286.8
273
*
R18
ICD-10 Finland
Ascites
25.8
286.6
408
170
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
283.6
270
*
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
+∞
281.5
268
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
275.1
262
*
WF002
NOMESCO Finland
Radical radiotherapy
82.1
274.8
310
40
TPH07
NOMESCO Finland
Cathetrisation of artery
5.1
273.1
962
2192
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
+∞
271.9
259
*
LCA06
NOMESCO Finland
Biopsy of endometrium
3.6
269.2
1447
4910
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
34.0
267.6
354
111
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
684.6
267.0
262
*
JAL00
NOMESCO Finland
Biopsy of peritoneum
85.3
259.2
291
36
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
80.2
255.4
289
38
L02BA01
ATC
tamoxifen; oral
236.6
242.9
249
11
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.2
242.4
1546
5914
WW500
NOMESCO Finland
Blood transfusion
11.8
242.4
466
427
8441/3-C56.9
ICD-O-3
Serous carcinoma, NOS, of ovary
+∞
241.2
230
*
WX402
NOMESCO Finland
General anaesthesia
3.9
240.1
1165
3586
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
237.0
226
*
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
+∞
236.0
225
*
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
6.0
233.8
706
1327
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
2223.0
232.6
224
*
C54.10
ICD-10 Finland
Malignant tumor of endometrium without histology
+∞
223.3
213
*
C54.9
ICD-10 Finland
Malignant neoplasm: Corpus uteri, unspecified
+∞
221.2
211
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
9.7
220.3
471
527
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
+∞
215.9
206
*
X77
ICPC
Malignant neopl genital female other
441.8
214.9
214
5
HA1AA
NOMESCO Finland
X-ray mammography
6.4
214.7
607
1043
N02AA05
ATC
oxycodone; systemic
3.5
206.5
1133
3805
C54.19
ICD-10 Finland
Malignant tumor of endometrium, unspecified histology
+∞
205.3
196
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
518.3
202.9
201
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
58.2
202.3
240
43
ZX120
NOMESCO Finland
Intravenous
4.8
202.0
746
1750
LEB00
NOMESCO Finland
Biopsy of vagina
10.2
200.7
415
435
C54.14
ICD-10 Finland
Serous papillary carcinoma of the endometrium
+∞
197.9
189
*
JAL31
NOMESCO Finland
Laparoscopic omentectomy
143.1
194.7
207
15
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
193.7
185
*
8461/3-C57.0
ICD-O-3
High grade serous carcinoma of fallopian tube
+∞
191.6
183
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
191.6
183
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
392.1
190.9
191
5
8380/3-C56.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of ovary
+∞
187.4
179
*
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
1924.2
183.1
177
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
267.2
177.6
181
7
HAC20
NOMESCO Finland
Total mastectomy
172.7
175.7
184
11
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
99.8
175.2
193
20
8070/3-C53.9
ICD-O-3
Squamous cell carcinoma, NOS, of cervix uteri
+∞
173.7
166
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.7
172.6
466
745
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
167.4
160
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
24.1
166.6
241
104
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
165.3
158
*
A04AD12
ATC
aprepitant; systemic
1703.5
165.2
160
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
804.8
160.2
157
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
159.0
152
*
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
+∞
157.9
151
*
C53.02
ICD-10 Finland
Adenocarcinoma of the endocervix
+∞
157.9
151
*
LCD30
NOMESCO Finland
Radical hysterectomy
187.4
157.5
164
9
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
55.1
156.4
187
35
ZX080
NOMESCO Finland
Image guided radiotherapy
783.7
156.0
153
*
1820A
ICD-9 Finland
Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[CARCINOMA ENDOMETRII]
+∞
153.7
147
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
17.7
152.8
245
144
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
150.6
144
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
1514.5
149.5
145
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
198.9
149.4
155
8
WZC30
NOMESCO Finland
Teaching
3.5
146.8
780
2497
C50.99
ICD-10 Finland
Breast, unspecified
736.2
146.6
144
*
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
74.9
146.3
167
23
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
371.3
145.5
146
*
8441/3-C54.1
ICD-O-3
Serous carcinoma, NOS, of endometrium
+∞
142.2
136
*
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
+∞
142.2
136
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
1428.0
142.2
138
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
10.3
139.6
286
292
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
23.6
138.3
201
88
N85.1
ICD-10 Finland
Endometrial adenomatous hyperplasia
10.8
136.3
271
261
ULA02
NOMESCO Finland
Kolposcopy
3.1
136.0
857
3097
LE090
NOMESCO Finland
Profylactive radiotherapy of vulva and vagina
+∞
135.9
130
*
C54.12
ICD-10 Finland
Adenosquamous carcinoma of the endometrium
+∞
134.8
129
*
JAH01
NOMESCO Finland
Laparoscopy
5.1
134.3
458
969
JAQ00
NOMESCO Finland
Extensive excision of peritoneum
+∞
133.8
128
*
LCA13
NOMESCO Finland
Curettage of cervix and body of uterus
3.1
132.1
819
2922
JN4CD
NOMESCO Finland
Very extensive body CT
9.7
130.8
277
300
A04AA03
ATC
tropisetron; systemic
272.8
130.6
133
5
Z31.5
ICD-10 Finland
Genetic counselling
6.1
127.9
370
643
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
80.9
125.8
142
18
C57.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of female genital organs
+∞
125.4
120
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
219.6
125.2
129
6
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
14.1
124.9
219
161
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.0
124.2
793
2879
JAH00
NOMESCO Finland
Laparotomy
8.0
123.6
294
387
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.8
122.1
901
3590
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
1191.7
120.2
117
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
33.8
119.8
158
48
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
10.7
119.1
238
231
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
1170.8
118.1
115
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
28.2
117.4
162
59
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.7
117.2
355
652
WF004
NOMESCO Finland
Palliative radiotherapy
303.0
116.5
118
*
L01BC06
ATC
capecitabine; oral
+∞
113.8
109
*
8070/3-C51.9
ICD-O-3
Squamous cell carcinoma, NOS, of vulva, NOS
+∞
112.8
108
*
A79
ICPC
Malignancy NOS
136.0
112.4
120
9
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
111.7
107
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
10.1
111.3
229
235
WF090
NOMESCO Finland
Profylactic radiotherapy
1087.6
109.7
107
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
1087.6
109.7
107
*
C51.01
ICD-10 Finland
Squamous cell carcinoma of the labium majus
+∞
109.6
105
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
1066.9
107.7
105
*
C56.92
ICD-10 Finland
Malignant ovarian tumor, sex chord stroma derived
+∞
105.5
101
*
C54.13
ICD-10 Finland
Clear cell carcinoma of the endometrium
+∞
104.4
100
*
LFC00
NOMESCO Finland
Partial excision of vulva
45.0
103.4
128
29
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
17.2
103.4
167
100
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
102.3
98
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
101.3
97
*
8310/3-C56.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of ovary
+∞
101.3
97
*
C56.74
ICD-10 Finland
Mesonephroid epithelial carcinoma of the ovary
+∞
101.3
97
*
8620/3-C56.9
ICD-O-3
Adult granulosa cell tumor of ovary of ovary
+∞
100.2
96
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
6.0
99.9
292
512
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
+∞
99.2
95
*
8140/3-C53.9
ICD-O-3
Adenocarcinoma, NOS, of cervix uteri
+∞
99.2
95
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
98.6
1418
7835
8470/3-C56.9
ICD-O-3
Mucinous cystadenocarcinoma, NOS, of ovary
+∞
98.1
94
*
3009
Kela drug reimbursment
Niraparib
+∞
98.1
94
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
98.1
94
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
942.6
95.1
93
*
1510
Kela drug reimbursment
Niraparib
+∞
95.0
91
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
318.4
94.1
95
*
LCD31
NOMESCO Finland
Radical laparoscopic hysterectomy
314.9
93.1
94
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
90.8
87
*
8460/3-C56.9
ICD-O-3
Low grade serous carcinoma of ovary
+∞
89.7
86
*
TJA10
NOMESCO Finland
Laparocentesis
108.3
88.1
96
9
Z51.0
ICD-10 Finland
Radiotherapy session
870.3
87.8
86
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
860.0
86.8
85
*
ULC02
NOMESCO Finland
Hysteroscopy
3.0
86.8
540
1898
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
88.7
86.2
96
11
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
85.7
677
2765
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
85.6
82
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
85.4
504
1708
WF099
NOMESCO Finland
Other radiotherapy
51.3
83.7
101
20
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
83.7
2340
16215
1XC07
NOMESCO Finland
NA
+∞
83.5
80
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
82.4
79
*
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
78.8
82.3
93
12
ZZR00
NOMESCO Finland
Flap of skin
19.9
81.9
125
64
N02BE01
ATC
paracetamol; systemic, rectal
2.2
81.4
4844
42783
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
81.4
78
*
C54
ICD-10 Finland
Malignant neoplasm of corpus uteri
798.2
80.6
79
*
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
+∞
80.3
77
*
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
4.0
80.3
344
903
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
18.9
79.7
124
67
C51.11
ICD-10 Finland
Squamous cell carcinoma of the labium minus
788.0
79.5
78
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
79.3
76
*
C56.91
ICD-10 Finland
Malignant granulosa cell tumor in ovary
+∞
77.2
74
*
L01XK02
ATC
niraparib; oral
+∞
77.2
74
*
L02BG03
ATC
anastrozole; oral
387.0
76.9
77
*
ZXC40
NOMESCO Finland
Use of ultrasound
15.4
76.2
128
85
C54.23
ICD-10 Finland
Carcinosarcoma
+∞
76.1
73
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
76.1
73
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
136.7
76.0
81
6
C54.21
ICD-10 Finland
Leiomyosarcoma and myometrium
+∞
75.1
72
*
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
11.6
74.7
142
125
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
28.0
74.1
102
37
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
716.1
72.2
71
*
N84.0
ICD-10 Finland
Polyp of corpus uteri
2.4
71.8
702
3197
C50
ICD-10 Finland
Malignant neoplasm of breast
361.2
71.7
72
*
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
6.1
71.4
204
347
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
705.8
71.2
70
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
151.7
71.1
75
5
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
6.3
70.9
197
323
C55
ICD-10 Finland
Malignant neoplasm of uterus, part unspecified
+∞
69.9
67
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
69.9
67
*
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
350.9
69.7
70
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.7
69.2
534
2138
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
33.8
68.6
90
27
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
19.6
67.9
104
54
C54.0
ICD-10 Finland
Malignant neoplasm: Isthmus uteri
+∞
67.8
65
*
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
+∞
67.8
65
*
C51.9
ICD-10 Finland
Malignant neoplasm: Vulva, unspecified
+∞
67.8
65
*
LFD10
NOMESCO Finland
Vulvectomy and excision of regional lymph nodes
+∞
65.7
63
*
JFB00
NOMESCO Finland
Partial resection of small intestine
7.9
65.2
153
197
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
64.6
62
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
222.1
64.2
66
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
63.6
61
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
18.4
62.7
98
54
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
62.6
692
3332
C54.22
ICD-10 Finland
Endometrial stromal cell sarcoma
+∞
62.6
60
*
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
62.6
60
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
61.5
59
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
61.5
542
2330
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.8
60.6
212
456
C53.00
ICD-10 Finland
Malignant tumor of endocervix without histology
+∞
60.5
58
*
R50.9
ICD-10 Finland
Fever, unspecified
2.2
60.3
658
3145
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
60.1
302
903
D07.0
ICD-10 Finland
Carcinoma in situ: Endometrium
44.0
59.8
74
17
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
3.4
59.7
303
913
JMA10
NOMESCO Finland
Transabdominal total splenectomy
29.3
59.7
81
28
N93.9
ICD-10 Finland
Abnormal uterine and vaginal bleeding, unspecified
5.1
58.9
193
387
121
Kela drug reimbursment
Severe hypofunction of sexual glands
4.2
58.7
236
583
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
58.4
56
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
8.9
57.8
126
144
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
2.7
57.3
419
1618
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
5.3
56.6
180
349
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
56.3
54
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
56.3
54
*
X76
ICPC
Malignant neoplasm breast female
121.0
55.8
60
5
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
55.2
53
*
C54.2
ICD-10 Finland
Malignant neoplasm: Myometrium
+∞
55.2
53
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
55.2
53
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
55.2
53
*
C574, 8461, 3
ICD-O-3
NA
+∞
55.2
53
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
55.2
53
*
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
9.7
55.0
114
119
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
5.1
54.4
178
356
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
9.9
54.1
111
114
A06AH03
ATC
naloxegol; oral
15.8
53.9
89
57
C53.12
ICD-10 Finland
Adenocarcinoma of the exocervix
532.0
53.6
53
*
JBA10
NOMESCO Finland
Transabdominal biopsy or excision of lesion of diaphragm
532.0
53.6
53
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.3
53.5
287
902
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
41.6
52.8
66
16
JFF10
NOMESCO Finland
Loop enterostomy
30.7
52.4
70
23
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
3.0
51.9
314
1073
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
35.6
51.9
67
19
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.4
51.6
196
459
8310
FHL
Radical hysterectomy (includes lymph node removal)
262.5
51.1
52
*
8140/3-C53.0
ICD-O-3
Adenocarcinoma, NOS, of endocervix
+∞
51.1
49
*
8310/3-C54.1
ICD-O-3
Clear cell adenocarcinoma, NOS, of endometrium
+∞
51.1
49
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
2.8
50.6
358
1354
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
9.4
50.4
106
114
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
8.4
50.3
113
136
C51.81
ICD-10 Finland
Squamous cell carcinoma of the vulva
+∞
50.0
48
*
18200
ICD-8 Finland
Other malignant neoplasm of uterus, Carcinoma corporis uteri
+∞
50.0
48
*
8480/3-C56.9
ICD-O-3
Mucinous adenocarcinoma of ovary
+∞
50.0
48
*
8076/3-C53.9
ICD-O-3
Squamous cell carcinoma, microinvasive of cervix uteri
+∞
50.0
48
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
50.0
48
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
12.0
49.5
92
78
JFB46
NOMESCO Finland
Resection of sigmoid colon
6.9
49.4
127
188
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
49.0
47
*
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
45.7
48.2
59
13
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
47.9
46
*
1511
Kela drug reimbursment
Olaparib
+∞
47.9
46
*
JFF23
NOMESCO Finland
Transversostomy
17.5
47.9
76
44
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
47.9
667
3519
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
8.7
47.6
105
123
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
470.8
47.3
47
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
5.4
47.3
148
282
LC003
NOMESCO Finland
Adjuvant radiotherapy of uterus and uterine ligaments
+∞
46.9
45
*
389
Kela drug reimbursment
Olaparib
+∞
46.9
45
*
D39.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified
11.4
46.8
89
79
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.7
46.4
333
1270
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
25.2
46.2
65
26
1XA02
NOMESCO Finland
NA
+∞
45.8
44
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
45.8
44
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
8.3
45.5
103
126
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.6
45.3
215
614
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
33.0
45.0
59
18
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
2.1
45.0
577
2939
C567
ICD-10 Finland
NA
+∞
44.8
43
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
44.8
43
*
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
+∞
44.8
43
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
440.2
44.2
44
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
44.1
996
6200
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
118.2
43.7
47
*
K56.7
ICD-10 Finland
Ileus, unspecified
5.9
43.5
126
219
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.8
43.3
291
1065
D39.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other female genital organs
19.0
43.0
66
35
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
221.2
42.9
44
*
Z93.3
ICD-10 Finland
Colostomy status
20.2
42.6
64
32
KA1FN
NOMESCO Finland
Isotope renography
14.9
42.3
71
48
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
419.9
42.2
42
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
216.1
41.9
43
*
C54.29
ICD-10 Finland
Unspecified uterine sarcoma
+∞
41.7
40
*
8140/3-C54.1
ICD-O-3
Adenocarcinoma, NOS, of endometrium
+∞
41.7
40
*
C53.09
ICD-10 Finland
Malignant tumor of endocervix, unspecified histology
+∞
40.6
39
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
53.6
40.4
48
9
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
27.7
40.2
55
20
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
2.3
40.1
391
1757
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
39.9
660
3697
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
39.6
38
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
39.6
38
*
L02BG06
ATC
exemestane; oral
+∞
39.6
38
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
39.6
38
*
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
+∞
39.6
38
*
8890/3-C54.9
ICD-O-3
Leiomyosarcoma, NOS, of corpus uteri
+∞
39.6
38
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
39.6
38
*
C51.00
ICD-10 Finland
Malignant tumor of the labium majus without histology
+∞
39.6
38
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
19.5
39.5
60
31
C53.0
ICD-10 Finland
Malignant neoplasm: Endocervix
389.4
39.1
39
*
8980/3-C54.1
ICD-O-3
Carcinosarcoma, NOS, of endometrium
+∞
38.5
37
*
JFB30
NOMESCO Finland
Right hemicolectomy
10.1
38.3
77
77
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
63.2
38.1
44
7
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.7
38.0
174
483
B01AB04
ATC
dalteparin; parenteral
2.5
37.9
309
1266
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
37.5
36
*
L01CB01
ATC
etoposide; systemic
+∞
37.5
36
*
J94.8
ICD-10 Finland
Other specified pleural conditions
6.3
37.3
102
165
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
42.0
37.1
46
11
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
+∞
36.5
35
*
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
+∞
36.5
35
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
36.5
35
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
36.5
35
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
29.0
36.3
49
17
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
9.8
36.3
74
76
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
185.8
35.8
37
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
185.8
35.8
37
*
S18
ICPC
Laceration/cut
1.5
35.7
2055
15951
L01XK01
ATC
olaparib; oral
+∞
35.4
34
*
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
+∞
35.4
34
*
8070/3-C53.1
ICD-O-3
Squamous cell carcinoma, NOS, of exocervix
+∞
35.4
34
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.2
34.9
136
328
C53.1
ICD-10 Finland
Malignant neoplasm: Exocervix
+∞
34.4
33
*
C52.91
ICD-10 Finland
Squamous cell carcinoma of the vagina
+∞
34.4
33
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
15.7
34.2
56
36
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
26.3
34.0
47
18
8102
FHL
Second look"" surgery for a malignant tumor
338.5
33.9
34
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
33.8
405
1997
ZX121
NOMESCO Finland
Central venous catheter
27.2
33.6
46
17
B03XA02
ATC
darbepoetin alfa; parenteral
5.5
33.4
101
186
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
+∞
33.3
32
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
33.3
32
*
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
4.4
32.7
121
278
SPAT1153
SPAT
Removal of sutures
1.5
32.6
1598
11946
N02AX02
ATC
tramadol; systemic, rectal
1.4
32.5
2097
16550
C579, 8461, 3
ICD-O-3
NA
+∞
32.3
31
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
32.3
31
*
8070/3-C52.9
ICD-O-3
Squamous cell carcinoma, NOS, of vagina, NOS
+∞
32.3
31
*
HAB99
NOMESCO Finland
Other partial excision of mammary gland
5.2
32.3
102
198
X81
ICPC
Genital neopl female other/unspecif
25.1
32.2
45
18
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
318.2
31.9
32
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
14.8
31.7
53
36
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
113.8
31.6
34
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.7
31.6
218
812
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.9
31.6
132
340
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
7.0
31.3
78
112
L01XX54
ATC
[U] niraparib; oral
+∞
31.2
30
*
C53.90
ICD-10 Finland
Malignant tumor in unspecified localization in cervix uteri without histology
+∞
31.2
30
*
C53.10
ICD-10 Finland
Malignant tumor of the exocervix without histology
+∞
31.2
30
*
3AA13
NOMESCO Finland
NA
+∞
31.2
30
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
31.2
30
*
KBV10
NOMESCO Finland
Removal of stent from ureter
10.1
31.0
62
62
LCA10
NOMESCO Finland
Curettage of body of uterus
2.7
30.9
217
816
C53
ICD-10 Finland
Malignant neoplasm of cervix uteri
313.9
30.8
31
*
JN5JS
NOMESCO Finland
Extensive PET-MRI of body metabolism
160.5
30.7
32
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
160.5
30.7
32
*
TJF80
NOMESCO Finland
Ostomy education
12.0
30.5
56
47
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
46.4
30.5
37
8
WX725
NOMESCO Finland
Noninvasive ventilation
2.6
30.5
230
903
C53.99
ICD-10 Finland
Malignant tumor in unspecified localization in cervix, unspecified histology
+∞
30.2
29
*
1800A
ICD-9 Finland
Malignant neoplasm of cervix uteri, Endocervix
+∞
30.2
29
*
8890/3-C54.2
ICD-O-3
Leiomyosarcoma, NOS, of myometrium
+∞
30.2
29
*
LDA10
NOMESCO Finland
Curettage of cervix uteri
2.4
30.2
262
1108
WX704
NOMESCO Finland
Intubation
2.2
30.1
333
1587
XX1AD
NOMESCO Finland
Other CT-examination
107.1
29.6
32
*
LWA00
NOMESCO Finland
Repair of wound dehiscence in gynaecological surgery
17.8
29.5
46
26
R93.5
ICD-10 Finland
Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
3.5
29.4
139
398
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.0
29.3
96
195
JFA80
NOMESCO Finland
Suture of colon
26.8
29.2
40
15
8000/3-C56.9
ICD-O-3
Neoplasm, malignant of ovary
+∞
29.2
28
*
R2110
NOMESCO Finland
Giving the first information
2.0
28.8
408
2148
X75
ICPC
Malignant neoplasm cervix
292.8
28.8
29
*
XW2AT
NOMESCO Finland
Cytology of deep organ with ultrasound quidance
292.8
28.8
29
*
KA3EB
NOMESCO Finland
Antegrade pyelography
17.4
28.7
45
26
B02AA02
ATC
tranexamic acid; systemic
1.6
28.7
842
5569
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
5.7
28.6
84
150
JFA70
NOMESCO Finland
Suture of small intestine
14.6
28.6
48
33
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.5
28.4
236
975
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
26.1
28.3
39
15
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
28.1
27
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
28.1
27
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
28.1
27
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
28.1
27
*
D39.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ovary
7.8
28.0
65
84
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
14.9
27.7
46
31
ZX112
NOMESCO Finland
Subcutaneous
6.1
27.5
76
126
KCD02
NOMESCO Finland
Transurethral resection of bladder
13.9
27.5
47
34
TPX15
NOMESCO Finland
Removal of vascular injection port
19.6
27.3
41
21
LC2HE
NOMESCO Finland
Hystero-salpingography with ultrasound
2.3
27.2
258
1145
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
27.1
26
*
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
+∞
27.1
26
*
C54.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of corpus uteri
+∞
27.1
26
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
62.2
26.9
31
5
N81.2
ICD-10 Finland
Incomplete uterovaginal prolapse
0.4
26.9
109
2690
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
31.9
26.8
35
11
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
41.3
26.7
33
8
LAF17
NOMESCO Finland
Laparoscopic excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
271.7
26.7
27
*
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
6.0
26.6
74
124
SPAT1109
SPAT
Analgesia with portable analgesic pump
11.7
26.6
49
42
C51.04
ICD-10 Finland
Basal cell carcinoma of labium majus
+∞
26.0
25
*
LWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gynaecological surgery
18.3
26.0
40
22
P01AB01
ATC
metronidazole; oral, rectal
1.4
26.0
2122
17246
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.2
25.8
101
246
LFD00
NOMESCO Finland
Vulvectomy
261.2
25.7
26
*
A02BC02
ATC
pantoprazole; systemic
1.4
25.2
3375
29660
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
9.3
25.1
52
56
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
13.0
25.1
44
34
18099
ICD-8 Finland
Malignant neoplasm of cervix uteri
+∞
25.0
24
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
25.0
24
*
JJA40
NOMESCO Finland
Excision of lesion of liver
+∞
25.0
24
*
L01XX46
ATC
[U] olaparib; oral
+∞
25.0
24
*
8070/3-C51.1
ICD-O-3
Squamous cell carcinoma, NOS, of labium minus
+∞
25.0
24
*
8070/3-C51.0
ICD-O-3
Squamous cell carcinoma, NOS, of labium majus
+∞
25.0
24
*
K62.7
ICD-10 Finland
Radiation proctitis
+∞
25.0
24
*
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
4.3
25.0
94
221
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
16.1
24.9
40
25
D07.1
ICD-10 Finland
Carcinoma in situ: Vulva
23.4
24.7
35
15
JFB53
NOMESCO Finland
Resection of sigmoid colon with partial proctectomy
42.9
24.5
30
7
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
6.0
24.5
68
114
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.6
24.3
71
127
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
34.5
24.2
31
9
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
5.3
24.2
75
144
1CD02
NOMESCO Finland
NA
+∞
23.9
23
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
23.9
23
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
23.9
23
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
23.9
23
*
N85.0
ICD-10 Finland
Endometrial glandular hyperplasia
2.8
23.9
154
550
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
9.1
23.9
50
55
J01DB01
ATC
cefalexin; oral
1.4
23.8
4054
36850
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
7.4
23.5
56
76
KBV00
NOMESCO Finland
Insertion of stent into ureter
8.3
23.5
52
63
KCH00
NOMESCO Finland
Suture of bladder
11.7
23.4
43
37
R4190
NOMESCO Finland
Nutritional therapy
3.3
23.2
120
370
G03AC03
ATC
levonorgestrel; systemic
0.5
23.2
257
4549
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
12.5
23.0
41
33
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
22.9
22
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
22.9
22
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
22.9
22
*
8070/3-C53.0
ICD-O-3
Squamous cell carcinoma, NOS, of endocervix
+∞
22.9
22
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
22.9
22
*
1CD01
NOMESCO Finland
NA
+∞
22.9
22
*
HAC25
NOMESCO Finland
Radical mastectomy
+∞
22.9
22
*
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.9
22.9
339
1815
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
22.8
339
1817
Z70.8
ICD-10 Finland
Other sex counselling
13.0
22.8
40
31
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.8
22.6
408
2337
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
230.4
22.6
23
*
LEF13
NOMESCO Finland
Colpoperineoplasty and vaginal hysterectomy
0.3
22.5
46
1534
JFB20
NOMESCO Finland
Ileocaecal resection
9.4
22.4
46
49
SPAT1125
SPAT
Stoma care and guidance
3.4
21.9
107
316
8980/3-C56.9
ICD-O-3
Carcinosarcoma, NOS, of ovary
+∞
21.9
21
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
21.9
21
*
L02BA03
ATC
fulvestrant; parenteral
+∞
21.9
21
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
21.9
21
*
WC401
NOMESCO Finland
Simple antibody therapy of local recurrence of tumour
+∞
21.9
21
*
C53.81
ICD-10 Finland
Overall squamous cell carcinoma of the cervix uteri
+∞
21.9
21
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
21.8
1744
14012
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
21.6
289
1489
XX1XN
NOMESCO Finland
Other isotope examination
115.2
21.5
23
*
WX400
NOMESCO Finland
Inhalation anesthesy
2.3
21.2
199
879
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
10.3
21.0
41
40
UKC02
NOMESCO Finland
Cystoscopy
1.6
20.9
561
3608
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
20.8
20
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
20.8
20
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
20.8
20
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
20.8
20
*
8931/3-C54.1
ICD-O-3
Endometrial stromal sarcoma, low grade of endometrium
+∞
20.8
20
*
9080/3-C56.9
ICD-O-3
Teratoma, malignant, NOS, of ovary
+∞
20.8
20
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
20.8
20
*
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
+∞
20.8
20
*
C51.09
ICD-10 Finland
Malignant tumor of the labium majus, unspecified histology
+∞
20.8
20
*
C76.3
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Pelvis
+∞
20.8
20
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
37.2
20.7
26
7
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.8
20.4
86
226
N81.1
ICD-10 Finland
Cystocele
0.5
20.3
224
3974
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
5.4
20.3
61
114
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
8.8
20.2
43
49
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
5.0
20.0
64
128
C52.90
ICD-10 Finland
Malignant neoplasm of vagina without histologic examination
+∞
19.8
19
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
19.8
19
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
19.8
19
*
GD1AD
NOMESCO Finland
Thorax CT examination
2.5
19.8
160
656
A46
ICD-10 Finland
Erysipelas
1.6
19.7
608
4049
E66.01
ICD-10 Finland
Obesity due to excess calories
1.8
19.7
355
2034
C53.19
ICD-10 Finland
Malignant tumor of the exocervix, unspecified histology
200.2
19.5
20
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
200.2
19.5
20
*
JAW96
NOMESCO Finland
Other operation on abdominal wall, peritoneum, mesentery or omentum
9.8
19.5
39
40
T81.2
ICD-10 Finland
Accidental puncture and laceration during a procedure, not elsewhere classified
3.5
19.5
92
266
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
7.2
19.4
47
66
R11
ICD-10 Finland
Nausea and vomiting
1.7
19.3
422
2565
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
20.0
19.0
28
14
TQW20
NOMESCO Finland
Tatoe
20.0
19.0
28
14
NK6AN
NOMESCO Finland
Total body bone isotope imaging
8.7
18.8
40
46
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
3.7
18.7
82
223
8140/3-C56.9
ICD-O-3
Adenocarcinoma, NOS, of ovary
+∞
18.7
18
*
C48.20
ICD-10 Finland
Malignant tumor in unspecified localization in the peritoneum without histology
+∞
18.7
18
*
394
Kela drug reimbursment
Palbociclib
+∞
18.7
18
*
8090/3-C51.9
ICD-O-3
Basal cell carcinoma, NOS, of vulva, NOS
+∞
18.7
18
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
18.7
18
*
C53.91
ICD-10 Finland
Squamous cell carcinoma in an unspecified location in the cervix
+∞
18.7
18
*
1501
Kela drug reimbursment
Palbociclib
+∞
18.7
18
*
R07.4
ICD-10 Finland
Chest pain, unspecified
0.7
18.6
871
11423
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
100.2
18.5
20
*
TLE30
NOMESCO Finland
Tamponation of vagina
9.8
18.5
37
38
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
3.0
18.4
106
354
K56.0
ICD-10 Finland
Paralytic ileus
5.5
18.3
54
99
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
9.1
18.3
38
42
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
4.7
18.3
62
133
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
44.0
18.2
22
5
5703
FHL
Removal of lymph nodes from the retroperitoneal space
25.0
18.2
25
10
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
7.8
18.0
41
53
D69.5
ICD-10 Finland
Secondary thrombocytopenia
11.4
17.9
33
29
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
2.2
17.9
176
795
Z51.88
ICD-10 Finland
Other specified medical care
2.9
17.8
108
373
N13.1
ICD-10 Finland
Hydronephrosis with ureteral stricture, not elsewhere classified
11.9
17.7
32
27
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
17.7
17
*
GAE03
NOMESCO Finland
Suture of chest wall
+∞
17.7
17
*
C51.1
ICD-10 Finland
Malignant neoplasm: Labium minus
+∞
17.7
17
*
JBA20
NOMESCO Finland
Transabdominal partial excision of diaphragm
+∞
17.7
17
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
17.7
17
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
17.7
17
*
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
13.7
17.7
30
22
KAC10
NOMESCO Finland
Total nephrectomy with capsule
20.0
17.7
26
13
WX892
NOMESCO Finland
Monitored bed care
1.8
17.7
311
1769
ZX100
NOMESCO Finland
Oral
4.0
17.7
70
175
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
95.1
17.5
19
*
N30.4
ICD-10 Finland
Irradiation cystitis
95.1
17.5
19
*
LAG11
NOMESCO Finland
Laparoscopic oophoropexy
180.1
17.5
18
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
180.1
17.5
18
*
JBA00
NOMESCO Finland
Transabdominal repair of diaphragm for rupture
180.1
17.5
18
*
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
180.1
17.5
18
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
8.0
17.4
39
49
PJA10
NOMESCO Finland
Exploration of lymph nodes
6.2
17.3
46
74
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
42.0
17.2
21
5
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
42.0
17.2
21
5
LAF01
NOMESCO Finland
Laparoscopic unilateral salpingo-oophorectomy
2.4
16.9
150
644
R03DC03
ATC
montelukast; oral
0.6
16.9
413
6092
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
16.9
348
2079
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
3.6
16.8
75
208
R03AC02
ATC
salbutamol; inhalant
0.8
16.8
1991
23086
8205
FHL
Subradical ovarian malignancy removal (includes possible genital and omet removal)
63.4
16.7
19
*
9060/3-C56.9
ICD-O-3
Dysgerminoma of ovary
+∞
16.7
16
*
C53.89
ICD-10 Finland
Overall malignant tumor of the cervix uteri, unspecified histology
+∞
16.7
16
*
WC402
NOMESCO Finland
Demanding antibody therapy of local recurrence of tumour
+∞
16.7
16
*
1801A
ICD-9 Finland
Malignant neoplasm of cervix uteri, Exocervix
+∞
16.7
16
*
8010/3-C56.9
ICD-O-3
Carcinoma, NOS, of ovary
+∞
16.7
16
*
C48.19
ICD-10 Finland
Malignant tumor in specified location in peritoneum other or unspecified histlogy
+∞
16.7
16
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
16.7
16
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
16.7
16
*
8440/3-C56.9
ICD-O-3
Cystadenocarcinoma, NOS, of ovary
+∞
16.7
16
*
C78.5
ICD-10 Finland
Secondary malignant neoplasm of large intestine and rectum
+∞
16.7
16
*
C51.19
ICD-10 Finland
Adenocarcinoma of the labium minus, unspecified histology
+∞
16.7
16
*
8441/3-C57.0
ICD-O-3
Serous carcinoma, NOS, of fallopian tube
+∞
16.7
16
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
16.7
16
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
16.7
16
*
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
+∞
16.7
16
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.1
16.6
180
854
X12
ICPC
Postmenopausal bleeding
3.9
16.6
68
176
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
170.1
16.5
17
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.7
16.4
360
2191
HA1SA
NOMESCO Finland
Expansion mammography
13.4
16.4
28
21
Y83.6
ICD-10 Finland
Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
13.4
16.4
28
21
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
4.5
16.4
57
126
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.0
16.3
214
1097
N81.6
ICD-10 Finland
Rectocele
0.6
16.2
227
3788
2180A
ICD-9 Finland
Uterine leiomyoma, Submucous leiomyoma of uterus
0.5
16.1
176
3133
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
30.0
16.1
21
7
UJF32
NOMESCO Finland
Coloscopy
1.3
16.0
1250
9907
C03CA01
ATC
furosemide; systemic
1.3
16.0
1486
12082
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
33.4
15.7
20
6
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
33.4
15.7
20
6
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
3.2
15.6
82
259
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
15.6
15
*
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
+∞
15.6
15
*
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
+∞
15.6
15
*
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
+∞
15.6
15
*
159
Kela drug reimbursment
Pazopanib
+∞
15.6
15
*
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
+∞
15.6
15
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
15.6
15
*
C50.01
ICD-10 Finland
Malignant tumor of nipple and areola, ductal tumor
+∞
15.6
15
*
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
+∞
15.6
15
*
C54.20
ICD-10 Finland
Malignant tumor of the myometrium without histology
+∞
15.6
15
*
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
15.6
15
*
Z08.2
ICD-10 Finland
Follow-up examination after chemotherapy for malignant neoplasm
+∞
15.6
15
*
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
+∞
15.6
15
*
C57.7
ICD-10 Finland
Malignant neoplasm: Other specified female genital organs
+∞
15.6
15
*
8542/3-C51.9
ICD-O-3
Paget disease, extramammary of vulva, NOS
+∞
15.6
15
*
8980/3-C54.9
ICD-O-3
Carcinosarcoma, NOS, of corpus uteri
+∞
15.6
15
*
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
+∞
15.6
15
*
A41.9
ICD-10 Finland
Sepsis, unspecified
2.3
15.6
141
612
C52.99
ICD-10 Finland
Malignant tumor of the vagina, unspecified histology
85.1
15.5
17
*
JJB10
NOMESCO Finland
Atypcal resection of liver
85.1
15.5
17
*
A98
ICPC
Health maint/preventive medicine
0.7
15.5
4712
48946
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
160.1
15.5
16
*
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.6
15.4
213
3569
TQB05
NOMESCO Finland
Puncture of skin of trunk
10.4
15.1
29
28
ZZR10
NOMESCO Finland
Flap of skin and muscle
13.0
15.1
26
20
RS220
NOMESCO Finland
NA
3.8
15.1
64
171
JAL96
NOMESCO Finland
Other excision of lesion of peritoneum
20.0
15.1
22
11
G02BA03
ATC
plastic IUD with progestogen
0.5
15.0
151
2753
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.9
15.0
210
1105
C10AA07
ATC
rosuvastatin; oral
0.7
14.8
779
10088
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
14.8
4457
41973
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
56.7
14.8
17
*
JN6AD
NOMESCO Finland
CT of torso and neck
7.9
14.7
33
42
KC1GB
NOMESCO Finland
Cystography with X-ray
11.3
14.7
27
24
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.6
14.7
108
423
JAA10
NOMESCO Finland
Excision of lesion of abdominal wall
18.4
14.6
22
12
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
18.4
14.6
22
12
S77
ICPC
Malignant neoplasm of skin
13.2
14.6
25
19
C53.9
ICD-10 Finland
Malignant neoplasm: Cervix uteri, unspecified
+∞
14.6
14
*
C53.92
ICD-10 Finland
Adenocarcinoma in an unspecified location in the cervix
+∞
14.6
14
*
C51.21
ICD-10 Finland
Squamous cell carcinoma of the clitoris
+∞
14.6
14
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
14.6
14
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
80.1
14.5
16
*
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
10.8
14.4
27
25
A40.8
ICD-10 Finland
Other streptococcal sepsis
5.5
14.4
42
77
JN3DM
NOMESCO Finland
Abdominal very extensive MRI examination with 3 Tesla magnet
36.0
14.4
18
5
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
10.0
14.4
28
28
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.8
14.4
94
344
D75
ICPC
Malignant neoplasm colon/rectum
27.2
14.2
19
7
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
14.1
1210
9703
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
3.3
14.0
70
214
KBH20
NOMESCO Finland
Replantation of ureter
10.9
13.9
26
24
WX600
NOMESCO Finland
Single shot through catheter
4.0
13.9
55
139
C90.0
ICD-10 Finland
Multiple myeloma
53.3
13.8
16
*
R01AD09
ATC
mometasone; nasal
0.8
13.8
1580
18529
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
75.1
13.6
15
*
K65.0
ICD-10 Finland
Acute peritonitis
4.1
13.5
52
128
ZX050
NOMESCO Finland
Stereotactic radiotherapy
12.0
13.5
24
20
1DB01
NOMESCO Finland
NA
+∞
13.5
13
*
JFC20
NOMESCO Finland
Other enterocolostomy
+∞
13.5
13
*
C52.92
ICD-10 Finland
Adenocarcinoma of the vagina
+∞
13.5
13
*
8480/3-C50.9
ICD-O-3
Mucinous adenocarcinoma of breast, NOS
+∞
13.5
13
*
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
+∞
13.5
13
*
OAB39
NOMESCO Finland
Sexual health guidance
+∞
13.5
13
*
C18.19
ICD-10 Finland
Malignant tumor in appendix other or unspecified histology
+∞
13.5
13
*
C58
ICD-10 Finland
Malignant neoplasm of placenta
+∞
13.5
13
*
8720/3-C51.9
ICD-O-3
Malignant melanoma, NOS, of vulva, NOS
+∞
13.5
13
*
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
+∞
13.5
13
*
C51.89
ICD-10 Finland
Overall malignant tumor of the vulva, unspecified histology
+∞
13.5
13
*
192
Kela drug reimbursment
Fulvestrant
+∞
13.5
13
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
13.5
13
*
E89.4
ICD-10 Finland
Postprocedural ovarian failure
34.0
13.5
17
5
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
34.0
13.5
17
5
GAE06
NOMESCO Finland
Excision of lesion of chest wall
34.0
13.5
17
5
LAE20
NOMESCO Finland
Bilateral oophorectomy
4.6
13.5
46
101
KCC30
NOMESCO Finland
Cystectomy with excision of female internal genital organs
140.0
13.4
14
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
140.0
13.4
14
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.8
13.4
85
306
JFF30
NOMESCO Finland
Other colostomy
16.2
13.4
21
13
XLD10
NOMESCO Finland
Gynaecological examination
5.4
13.4
39
72
T80.2
ICD-10 Finland
Infections following infusion, transfusion and therapeutic injection
25.7
13.3
18
7
JFB50
NOMESCO Finland
Other resection of colon
11.4
13.2
24
21
5702
FHL
Local lymph node removal (eg armpit, groin)
13.8
13.2
22
16
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
15.0
13.0
21
14
WX110
NOMESCO Finland
Local anesthesy
1.2
13.0
3065
27710
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
8.7
12.9
27
31
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.8
12.9
80
283
J91
ICD-10 Finland
Pleural effusion in conditions classified elsewhere
19.0
12.9
19
10
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
50.0
12.8
15
*
C10AA05
ATC
atorvastatin; oral
0.8
12.8
1378
16313
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.5
12.7
98
394
Y60.8
ICD-10 Finland
Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during other surgical and medical care
9.6
12.7
25
26
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
3.7
12.6
53
142
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
69.9
12.6
14
*
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
12.2
12.6
22
18
C79.6
ICD-10 Finland
Secondary malignant neoplasm of ovary
+∞
12.5
12
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
12.5
12
*
C51.0
ICD-10 Finland
Malignant neoplasm: Labium majus
+∞
12.5
12
*
8090/3-C51.0
ICD-O-3
Basal cell carcinoma, NOS, of labium majus
+∞
12.5
12
*
C52
ICD-10 Finland
Malignant neoplasm of vagina
+∞
12.5
12
*
JN5KS
NOMESCO Finland
Very extensive PET-MRI of body metabolism
+∞
12.5
12
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
+∞
12.5
12
*
D63.0
ICD-10 Finland
Anaemia in neoplastic disease
+∞
12.5
12
*
L01XE33
ATC
[U] palbociclib; oral
+∞
12.5
12
*
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
12.5
12
*
8010/3-C50.9
ICD-O-3
Carcinoma, NOS, of breast, NOS
+∞
12.5
12
*
L01CA04
ATC
vinorelbine; systemic
+∞
12.5
12
*
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
+∞
12.5
12
*
PJ1AN
NOMESCO Finland
Lymphsystem isotope imaging
17.3
12.5
19
11
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
0.7
12.5
542
7239
QWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of skin
5.7
12.5
35
62
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
20.0
12.4
18
9
LEC00
NOMESCO Finland
Partial excision of vagina
13.1
12.4
21
16
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
6.0
12.3
33
55
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.6
12.2
54
151
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.0
12.2
146
725
M03BX02
ATC
tizanidine; oral
0.8
12.1
2429
26988
N85.9
ICD-10 Finland
Noninflammatory disorder of uterus, unspecified
3.1
12.0
64
207
KCD10
NOMESCO Finland
Partial cystectomy
46.6
11.9
14
*
D77
ICPC
Malignant digestive neopl other/NOS
46.6
11.9
14
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.8
11.8
75
271
SPAT1262
SPAT
Handing over of treatment supplies
1.3
11.8
773
5937
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.7
11.8
510
6822
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
11.7
547
7233
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
7.3
11.7
27
37
JFB40
NOMESCO Finland
Resection of transverse colon
16.4
11.6
18
11
DHB00
NOMESCO Finland
Excision of lesion of external nose
7.7
11.6
26
34
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.9
11.6
46
118
JG1BG
NOMESCO Finland
MRI of rectum
18.9
11.6
17
9
JGB10
NOMESCO Finland
Partial proctectomy and end colostomy
22.9
11.5
16
7
N82.0
ICD-10 Finland
Vesicovaginal fistula
11.1
11.5
21
19
C51.13
ICD-10 Finland
Melanoma and labium minus
+∞
11.4
11
*
WE198
NOMESCO Finland
Palliative cystotatic therapy
+∞
11.4
11
*
8930/3-C54.1
ICD-O-3
Endometrial stromal sarcoma, NOS, of endometrium
+∞
11.4
11
*
L01EF01
ATC
palbociclib; oral
+∞
11.4
11
*
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
+∞
11.4
11
*
C50.32
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor
+∞
11.4
11
*
L01XE11
ATC
[U] pazopanib; oral
+∞
11.4
11
*
8522/3-C50.9
ICD-O-3
Infiltrating duct and lobular carcinoma of breast, NOS
+∞
11.4
11
*
8140/3-C54.9
ICD-O-3
Adenocarcinoma, NOS, of corpus uteri
+∞
11.4
11
*
C48.80
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum without histology
+∞
11.4
11
*
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
+∞
11.4
11
*
8380/3-C57.0
ICD-O-3
Endometrioid adenocarcinoma, NOS, of fallopian tube
+∞
11.4
11
*
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
11.4
11
*
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
+∞
11.4
11
*
8461/3-C54.1
ICD-O-3
High grade serous carcinoma of endometrium
+∞
11.4
11
*
8140/3-C53.1
ICD-O-3
Adenocarcinoma, NOS, of exocervix
+∞
11.4
11
*
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
+∞
11.4
11
*
C50.52
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor
+∞
11.4
11
*
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.6
11.4
38
82
PJW99
NOMESCO Finland
Other operation on lymphatic system
120.0
11.4
12
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
120.0
11.4
12
*
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
4.0
11.4
44
110
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.4
11.4
93
386
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.6
11.4
312
2018
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
0.5
11.3
118
2126
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
6.9
11.3
27
39
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.8
11.2
1141
13637
HA1HA
NOMESCO Finland
Tomosynthesis mammography
9.6
11.2
22
23
SAA02
NOMESCO Finland
Basic examination of mouth
0.8
11.1
2361
26187
R06AX27
ATC
desloratadine; oral
0.8
11.1
797
9935
M01AH05
ATC
etoricoxib; oral
0.8
11.1
2332
25890
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.6
11.1
48
133
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
10.8
615
4615
M25.5
ICD-10 Finland
Pain in joint
0.8
10.8
970
11764
R96
ICPC
Asthma
0.6
10.7
220
3373
JFF13
NOMESCO Finland
Terminal enterostomy
10.5
10.7
20
19
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
2.9
10.7
63
218
A21
ICPC
Risk factor for malignancy
28.0
10.7
14
5
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
28.0
10.7
14
5
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
0.7
10.6
245
3664
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
2.5
10.6
83
340
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
6.7
10.6
26
39
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
60.0
10.6
12
*
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
60.0
10.6
12
*
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
60.0
10.6
12
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
60.0
10.6
12
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.8
10.6
1114
13280
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.8
10.5
715
8983
N82.3
ICD-10 Finland
Fistula of vagina to large intestine
7.3
10.4
24
33
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
7.3
10.4
24
33
J45
ICD-10 Finland
Asthma
0.6
10.4
234
3516
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
10.4
10
*
8323/3-C54.1
ICD-O-3
Mixed cell adenocarcinoma of endometrium
+∞
10.4
10
*
C51.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of vulva
+∞
10.4
10
*
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
+∞
10.4
10
*
9071/3-C56.9
ICD-O-3
Yolk sac tumor, NOS, of ovary
+∞
10.4
10
*
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
10.4
10
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
10.4
10
*
180
Kela drug reimbursment
Interferon alfa
+∞
10.4
10
*
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
+∞
10.4
10
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
10.4
10
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
10.4
10
*
9110/3-C56.9
ICD-O-3
Mesonephroma, malignant of ovary
+∞
10.4
10
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
+∞
10.4
10
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
10.4
10
*
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
+∞
10.4
10
*
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
+∞
10.4
10
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
+∞
10.4
10
*
8140/3-C57.0
ICD-O-3
Adenocarcinoma, NOS, of fallopian tube
+∞
10.4
10
*
C18.11
ICD-10 Finland
Malignant tumor of the appendix invasive carcinoma
+∞
10.4
10
*
18220
ICD-8 Finland
NA
+∞
10.4
10
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
10.4
10
*
JFC10
NOMESCO Finland
Ileotransversostomy
110.0
10.4
11
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
110.0
10.4
11
*
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
110.0
10.4
11
*
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
110.0
10.4
11
*
SPAT1088
SPAT
Blood transfusion
5.4
10.4
30
56
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
6.4
10.3
26
41
TQW99
NOMESCO Finland
Other minor procedure on skin
1.8
10.3
159
871
WX610
NOMESCO Finland
Patient controlled analgesia
5.1
10.2
31
61
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.4
10.2
81
335
D48.49
ICD-10 Finland
Tumor of uncertain or unknown nature in the peritoneum, of unknown origin
23.3
10.2
14
6
JFB43
NOMESCO Finland
Left hemicolectomy
5.7
10.2
28
49
R83
ICPC
Respiratory infection other
0.7
10.1
504
6610
21899
ICD-8 Finland
Uterine fibroma
0.6
10.1
166
2667
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
10.1
589
4434
R05
ICPC
Cough
0.8
10.0
725
9037
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
40.0
9.9
12
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
40.0
9.9
12
*
B29
ICPC
Lymph/immune mech sympt/complt other
5.1
9.9
30
59
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.4
9.9
78
322
M01AB05
ATC
diclofenac; systemic, rectal
0.8
9.8
2744
29827
G03DA02
ATC
medroxyprogesterone; systemic (pregnen (4) derivatives)
1.3
9.8
663
5112
N13.9
ICD-10 Finland
Obstructive and reflux uropathy, unspecified
5.6
9.8
27
48
KMAK
NOMESCO Finland
NA
0.8
9.7
1816
20477
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.3
9.7
85
367
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.8
9.7
1395
16128
N76.6
ICD-10 Finland
Ulceration of vulva
3.0
9.7
54
182
R31
ICD-10 Finland
Unspecified haematuria
1.6
9.7
251
1602
TGA30
NOMESCO Finland
Thoracocentesis
5.3
9.6
28
53
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
5.5
9.6
27
49
LEF00
NOMESCO Finland
Anterior colporraphy with sutures for primary cystocele
0.6
9.6
124
2109
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.4
9.6
44
129
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
3.5
9.5
42
119
R03BA01
ATC
beclometasone; inhalant
0.7
9.5
402
5405
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
8.3
9.5
20
24
J01MA12
ATC
levofloxacin; systemic
1.3
9.5
675
5236
B03XA01
ATC
erythropoietin; parenteral
4.1
9.5
35
85
HAE99
NOMESCO Finland
Other reconstruction of breast
9.1
9.5
19
21
Z93
ICD-10 Finland
Artificial opening status
10.0
9.5
18
18
G56.0
ICD-10 Finland
Carpal tunnel syndrome
0.7
9.4
407
5459
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
100.0
9.4
10
*
JAL23
NOMESCO Finland
Excision of local lesion of pelvic wall
100.0
9.4
10
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
0.8
9.4
670
8375
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
6.6
9.4
23
35
8890/3-C55.9
ICD-O-3
Leiomyosarcoma, NOS, of uterus, NOS
+∞
9.4
9
*
LEE10
NOMESCO Finland
Repair of vagina using graft or flap
+∞
9.4
9
*
C53.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of cervix uteri
+∞
9.4
9
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
9.4
9
*
8140/3-C57.9
ICD-O-3
Adenocarcinoma, NOS, of female genital tract, NOS
+∞
9.4
9
*
8010/3-C54.1
ICD-O-3
Carcinoma, NOS, of endometrium
+∞
9.4
9
*
C50.5
ICD-10 Finland
Malignant neoplasm: Lower-outer quadrant of breast
+∞
9.4
9
*
LC002
NOMESCO Finland
Radical radiotherapy of uterus and uterine ligaments
+∞
9.4
9
*
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
+∞
9.4
9
*
C18.29
ICD-10 Finland
Malignant tumor of the ascending colon or other unspecified histology
+∞
9.4
9
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
9.4
9
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
9.4
9
*
LCE20
NOMESCO Finland
Total exenteration of female pelvis
+∞
9.4
9
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
+∞
9.4
9
*
8000/3-C57.9
ICD-O-3
Neoplasm, malignant of female genital tract, NOS
+∞
9.4
9
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
9.4
9
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
9.4
9
*
C539, 8085, 3
ICD-O-3
NA
+∞
9.4
9
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
21.7
9.3
13
6
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.9
9.3
54
186
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
8.0
9.3
20
25
Y60.0
ICD-10 Finland
Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during surgical operation
4.7
9.3
30
64
M54.5
ICD-10 Finland
Low back pain
0.8
9.3
1158
13588
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
1.9
9.3
137
740
LBE10
NOMESCO Finland
Bilateral salpingectomy
10.6
9.3
17
16
R87.7
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal histological findings
4.5
9.2
31
69
R60.0
ICD-10 Finland
Localized oedema
1.4
9.2
526
3947
SPAT1076
SPAT
Cannulation of central vein
13.6
9.2
15
11
8308
FHL
Hysterectomy and bilateral adnexal removal
1.8
9.1
157
895
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
7.7
9.1
20
26
Z30.1
ICD-10 Finland
Insertion of (intrauterine) contraceptive device
0.5
9.1
86
1591
Z43.3
ICD-10 Finland
Attention to colostomy
15.6
9.0
14
9
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
36.7
9.0
11
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
36.7
9.0
11
*
WX720
NOMESCO Finland
Own respiration
1.8
9.0
150
844
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
3.1
8.9
47
153
SPAT1255
SPAT
Intravenous administration of medicine
1.5
8.9
257
1685
I89.8
ICD-10 Finland
Other specified noninfective disorders of lymphatic vessels and lymph nodes
18.6
8.9
13
7
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.8
8.9
153
870
LEE00
NOMESCO Finland
Suture of vagina
5.2
8.9
26
50
JKA20
NOMESCO Finland
Cholecystectomy
2.0
8.8
105
525
C10AX09
ATC
ezetimibe; oral
0.7
8.8
252
3617
N99.3
ICD-10 Finland
Prolapse of vaginal vault after hysterectomy
0.4
8.8
41
956
L01
ICPC
Neck symptom/complaint
0.7
8.8
406
5388
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.7
8.8
215
3178
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
2.4
8.8
70
290
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
0.7
8.8
234
3400
Z93.2
ICD-10 Finland
Ileostomy status
6.3
8.7
22
35
M05BA02
ATC
clodronic acid; systemic
14.0
8.7
14
10
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
49.9
8.7
10
*
V03AF03
ATC
calcium folinate; systemic
49.9
8.7
10
*
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
7.6
8.6
19
25
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.8
8.5
133
733
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.8
8.5
515
6582
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
8.5
287
1948
A40.1
ICD-10 Finland
Sepsis due to streptococcus, group B
8.2
8.5
18
22
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
0.7
8.5
348
4709
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.8
8.5
135
749
N02AA01
ATC
morphine; systemic, rectal
3.4
8.5
39
115
L08
ICPC
Shoulder symptom/complaint
0.8
8.5
614
7669
P20
ICPC
Memory disturbance
0.7
8.5
414
5447
Z43.2
ICD-10 Finland
Attention to ileostomy
27.5
8.5
11
*
JGB04
NOMESCO Finland
Laparoscopic partial proctectomy with partial excision of mesorectum
20.0
8.4
12
6
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
20.0
8.4
12
6
C76.8
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites
90.0
8.4
9
*
KKA10
NOMESCO Finland
Biopsy of retroperitoneal tissue
90.0
8.4
9
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
90.0
8.4
9
*
C18.31
ICD-10 Finland
Malignant tumor of flexura hepatica invasive carcinoma
90.0
8.4
9
*
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
90.0
8.4
9
*
R01AD08
ATC
fluticasone; nasal
0.8
8.3
905
10797
8140/3-C19.9
ICD-O-3
Adenocarcinoma, NOS, of rectosigmoid junction
+∞
8.3
8
*
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
+∞
8.3
8
*
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
+∞
8.3
8
*
1820C
ICD-9 Finland
Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[SARCOMA MYOMETRI]
+∞
8.3
8
*
8140/3-C18.4
ICD-O-3
Adenocarcinoma, NOS, of transverse colon
+∞
8.3
8
*
1742A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-inner quadrant
+∞
8.3
8
*
18221
ICD-8 Finland
NA
+∞
8.3
8
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
8.3
8
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
8.3
8
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
8.3
8
*
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
+∞
8.3
8
*
C48.10
ICD-10 Finland
Malignant tumor in specified location in the peritoneum without histology
+∞
8.3
8
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
8.3
8
*
L02BA02
ATC
toremifene; oral
+∞
8.3
8
*
8480/1-C18.1
ICD-O-3
Low grade appendiceal mucinous neoplasm of appendix
+∞
8.3
8
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
8.3
8
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
8.3
8
*
1745A
ICD-9 Finland
Malignant neoplasm of female breast, Lower-outer quadrant
+∞
8.3
8
*
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
+∞
8.3
8
*
C50.1
ICD-10 Finland
Malignant neoplasm: Central portion of breast
+∞
8.3
8
*
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
+∞
8.3
8
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
8.3
8
*
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
+∞
8.3
8
*
18011
ICD-8 Finland
NA
+∞
8.3
8
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
8.3
8
*
8980/3-C54.2
ICD-O-3
Carcinosarcoma, NOS, of myometrium
+∞
8.3
8
*
SAA01
NOMESCO Finland
Simple examination of mouth
0.8
8.3
2760
29781
8306
FHL
Hysterectomy (related to abortion 8516, prolapse correction 8436)
0.6
8.3
96
1679
L03.3
ICD-10 Finland
Cellulitis of trunk
3.7
8.3
34
92
JG1CG
NOMESCO Finland
Extensive MRI of rectum
10.7
8.3
15
14
AN1
HP
Coronary angiography
0.7
8.3
254
3600
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.8
8.2
757
9195
N93.8
ICD-10 Finland
Other specified abnormal uterine and vaginal bleeding
2.1
8.2
84
396
JLC10
NOMESCO Finland
Distal pancreatectomy
14.4
8.2
13
9
J01CE08
ATC
benzathine benzylpenicillin; parenteral
2.9
8.2
47
161
A08
ICPC
Swelling
1.6
8.1
202
1279
AA1AD
NOMESCO Finland
CT of head and brain
0.8
8.1
786
9491
JJA20
NOMESCO Finland
Open biopsy of liver
8.1
8.1
17
21
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
17.1
8.1
12
7
L57.0
ICD-10 Finland
Actinic keratosis
1.4
8.0
361
2598
M19.0
ICD-10 Finland
Primary arthrosis of other joints
0.7
8.0
268
3746
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.4
8.0
65
272
4044
NOMESCO Finland
NA
22.0
8.0
11
5
A41.8
ICD-10 Finland
Other specified sepsis
2.5
7.9
56
221
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.7
7.8
154
916
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
3.6
7.8
33
92
E66.9
ICD-10 Finland
Obesity, unspecified
1.7
7.8
139
803
J45.1
ICD-10 Finland
Nonallergic asthma
0.6
7.7
149
2313
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.0
7.7
90
448
W12
ICPC
Contraception intrauterine
0.5
7.7
63
1214
Z30.5
ICD-10 Finland
Surveillance of (intrauterine) contraceptive device
0.5
7.7
54
1093
N93
ICD-10 Finland
Other abnormal uterine and vaginal bleeding
4.8
7.7
24
50
R03BA05
ATC
fluticasone; inhalant
0.8
7.7
548
6865
JGB30
NOMESCO Finland
Abdominoperineal excision of rectum
44.9
7.7
9
*
JN4DD
NOMESCO Finland
Scout CT scan of torso
44.9
7.7
9
*
QB4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in groin or genital area (from front)
44.9
7.7
9
*
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
44.9
7.7
9
*
JGA60
NOMESCO Finland
Suture of rectum
15.0
7.7
12
8
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
3.4
7.6
35
104
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
7.4
7.6
17
23
J01MA02
ATC
ciprofloxacin; systemic
1.2
7.6
1667
14686
A11
ICPC
Chest pain NOS
0.7
7.6
183
2710
L88
ICPC
Rheumatoid/seropositive arthritis
0.5
7.6
79
1419
N05CF01
ATC
zopiclone; oral
1.2
7.6
1599
14040
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
2.7
7.6
47
172
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
2.5
7.6
54
214
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
25.0
7.6
10
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
25.0
7.6
10
*
ZLX00
NOMESCO Finland
Open surgery with vaginal approach
25.0
7.6
10
*
JFF24
NOMESCO Finland
Laparoscopic transversostomy
25.0
7.6
10
*
LCD11
NOMESCO Finland
Laparoscopically assisted vaginal hysterectomy
2.0
7.6
93
474
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
4.2
7.5
27
65
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
2.8
7.5
45
161
LCD97
NOMESCO Finland
Other laparoscopic hysterectomy
5.4
7.5
21
39
OAA41
NOMESCO Finland
Health check based on individual needs
80.0
7.4
8
*
SPAT1122
SPAT
Ascites puncture
80.0
7.4
8
*
J45.9
ICD-10 Finland
Asthma, unspecified
0.8
7.4
566
7026
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
6.4
7.4
18
28
JAH96
NOMESCO Finland
Other opening of peritoneal cavity
13.3
7.4
12
9
306
Kela drug reimbursment
Erythropoietin and darbepoetin
7.6
7.4
16
21
LBE01
NOMESCO Finland
Laparoscopic salpingectomy
2.1
7.4
80
388
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
5.9
7.3
19
32
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
0.8
7.3
685
8310
R03BA02
ATC
budesonide; inhalant
0.8
7.3
538
6710
D06.9
ICD-10 Finland
Carcinoma in situ: Cervix, unspecified
8.3
7.3
15
18
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
2.9
7.3
40
136
D39
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of female genital organs
+∞
7.3
7
*
L01AX03
ATC
temozolomide; systemic
+∞
7.3
7
*
343
Kela drug reimbursment
Pazopanib
+∞
7.3
7
*
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
7.3
7
*
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
+∞
7.3
7
*
8560/3-C53.9
ICD-O-3
Adenosquamous carcinoma of cervix uteri
+∞
7.3
7
*
8380/3-C53.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of cervix uteri
+∞
7.3
7
*
1844A
ICD-9 Finland
Malignant neoplasm of other and unspecified female genital organs, Vulva, unspecified
+∞
7.3
7
*
9100/3-C58.9
ICD-O-3
Choriocarcinoma, NOS, of placenta
+∞
7.3
7
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
7.3
7
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
7.3
7
*
WB131
NOMESCO Finland
Very demanding neoadjuvant cytostatic therapy
+∞
7.3
7
*
WC205
NOMESCO Finland
Simple therapy of local tumor recidive with hormone
+∞
7.3
7
*
LCF00
NOMESCO Finland
Excision of lesion of parametrium
+∞
7.3
7
*
LAG10
NOMESCO Finland
Oophoropexy
+∞
7.3
7
*
C80.98
ICD-10 Finland
Malignant tumor without specified localization other specified histology
+∞
7.3
7
*
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
+∞
7.3
7
*
C79.1
ICD-10 Finland
Secondary malignant neoplasm of bladder and other and unspecified urinary organs
+∞
7.3
7
*
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
7.3
7
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
7.3
7
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
7.3
7
*
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
+∞
7.3
7
*
C53.80
ICD-10 Finland
Overall malignant tumor of the cervix uteri without histology
+∞
7.3
7
*
C50.93
ICD-10 Finland
Malignant tumor in other specified localization in mammary gland other or unspecified histology
+∞
7.3
7
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
7.3
7
*
C18.51
ICD-10 Finland
Malignant tumor of flexura hiealis invasive carcinoma
+∞
7.3
7
*
6500B
ICD-9 Finland
Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]
0.8
7.2
508
6372
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
15.7
7.2
11
7
H02
ICPC
Hearing complaint
0.7
7.2
356
4679
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
0.6
7.2
78
1384
LCA98
NOMESCO Finland
Other transluminal endoscopic operation on uterus
2.7
7.2
46
170
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
30.0
7.1
9
*
D64.2
ICD-10 Finland
Secondary sideroblastic anaemia due to drugs and toxins
30.0
7.1
9
*
JA2CT
NOMESCO Finland
Abdominal puncture with CT guidance
30.0
7.1
9
*
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.6
7.1
172
1083
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
0.6
7.1
147
2247
C44.3
ICD-10 Finland
Malignant neoplasm: Skin of other and unspecified parts of face
20.0
7.1
10
5
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
20.0
7.1
10
5
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
5.0
7.1
21
42
A28
ICPC
Limited function/disability NOS
1.3
7.0
752
6152
R03AK06
ATC
salmeterol and fluticasone; inhalant
0.7
7.0
369
4810
N71.1
ICD-10 Finland
Chronic inflammatory disease of uterus
4.3
7.0
24
56
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
0.6
7.0
142
2172
J01FA10
ATC
azithromycin; systemic
0.9
7.0
2276
24739
L17
ICPC
Foot/toe symptom/complaint
0.8
6.9
927
10852
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.2
6.9
932
7827
D06.1
ICD-10 Finland
Carcinoma in situ: Exocervix
6.3
6.9
17
27
K83.1
ICD-10 Finland
Obstruction of bile duct
2.8
6.9
42
153
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
0.3
6.9
13
447
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
0.9
6.9
1997
21906
I89.9
ICD-10 Finland
Noninfective disorder of lymphatic vessels and lymph nodes, unspecified
7.5
6.9
15
20
GDC00
NOMESCO Finland
Lobectomy of lung
13.7
6.9
11
8
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.7
6.9
347
4549
R4110
NOMESCO Finland
Physiotherapy
1.2
6.9
1057
8997
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
1.6
6.8
186
1205
R03AK07
ATC
formoterol and budesonide; inhalant
0.8
6.8
525
6516
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
0.7
6.8
346
4534
N85.7
ICD-10 Finland
Haematometra
4.8
6.8
21
44
JFF26
NOMESCO Finland
Sigmoidostomy
10.9
6.8
12
11
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.6
6.8
124
1943
H02.3
ICD-10 Finland
Blepharochalasis
0.7
6.8
180
2618
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
39.9
6.7
8
*
XW4CT
NOMESCO Finland
Biopsy of other inner organ with CT guidance
39.9
6.7
8
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
39.9
6.7
8
*
153
Kela drug reimbursment
Lenalidomid
39.9
6.7
8
*
KBD00
NOMESCO Finland
Partial excision of ureter
39.9
6.7
8
*
D27.99
ICD-10 Finland
Benign tumor of the ovary (ovary), unspecified histology
2.8
6.7
40
143
R01BA52
ATC
pseudoephedrine, combinations; oral
0.8
6.7
1200
13695
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
2.6
6.7
44
167
N63
ICD-10 Finland
Unspecified lump in breast
1.5
6.7
231
1582
R74
ICPC
Upper respiratory infection acute
0.8
6.7
798
9451
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
4.7
6.7
21
45
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
7.1
6.7
15
21
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
0.9
6.7
1709
18936
8305
FHL
Supravaginal amputation or resection
0.5
6.6
42
875
R01AD12
ATC
fluticasone furoate; nasal
0.8
6.6
898
10505
SPAT1058
SPAT
PEF monitoring instruction
0.7
6.6
229
3178
LAE11
NOMESCO Finland
Unilateral laparoscopic oophorectomy
2.8
6.6
39
139
J94.9
ICD-10 Finland
Pleural condition, unspecified
5.1
6.6
19
37
N95
ICD-10 Finland
Menopausal and other perimenopausal disorders
0.4
6.6
30
698
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
0.7
6.6
189
2705
L13
ICPC
Hip symptom/complaint
0.8
6.5
629
7612
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
5.0
6.5
19
38
LWE00
NOMESCO Finland
Reoperation for deep haemorrhage in gynaecological surgery
3.1
6.5
33
108
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.6
6.4
163
1038
T88.9
ICD-10 Finland
Complication of surgical and medical care, unspecified
3.8
6.4
25
66
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.0
6.4
73
362
8441/2-C57.0
ICD-O-3
Serous intraepithelial carcinoma of fallopian tube
69.8
6.4
7
*
1XC03
NOMESCO Finland
NA
69.8
6.4
7
*
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
69.8
6.4
7
*
L04AX04
ATC
lenalidomide; oral
69.8
6.4
7
*
C44.01
ICD-10 Finland
Basocellular carcinoma of the lip skin
69.8
6.4
7
*
8477
FHL
Vulvectomy
69.8
6.4
7
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
69.8
6.4
7
*
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
14.3
6.4
10
7
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
3.4
6.4
28
82
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.8
6.4
414
5245
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
0.7
6.3
226
3120
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.1
6.3
66
317
L15
ICPC
Knee symptom/complaint
0.8
6.3
803
9451
JFK10
NOMESCO Finland
Freeing of adhesions in intestinal obstruction
4.2
6.3
22
53
XX1VW
NOMESCO Finland
Written report from radiologist
3.2
6.3
30
94
8071/2-C51.9
ICD-O-3
Differentiated intraepithelial neoplasia of vulva, NOS
18.0
6.2
9
5
C45.1
ICD-10 Finland
Mesothelioma of peritoneum
+∞
6.2
6
*
C66
ICD-10 Finland
Malignant neoplasm of ureter
+∞
6.2
6
*
WB313
NOMESCO Finland
Adjuvant multiple therapy of malignancy with biomodifiers
+∞
6.2
6
*
197
Kela drug reimbursment
Sunitinib
+∞
6.2
6
*
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
+∞
6.2
6
*
C18.22
ICD-10 Finland
Malignant tumor of the colon ascending carcinoma of the adenoma
+∞
6.2
6
*
C57.4
ICD-10 Finland
Malignant neoplasm: Uterine adnexa, unspecified
+∞
6.2
6
*
8480/3-C20.9
ICD-O-3
Mucinous adenocarcinoma of rectum, NOS
+∞
6.2
6
*
C51.03
ICD-10 Finland
Melanoma and labium majus
+∞
6.2
6
*
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
+∞
6.2
6
*
C18.61
ICD-10 Finland
Malignant tumor of the colon descending invasive carcinoma
+∞
6.2
6
*
C18.30
ICD-10 Finland
Malignant tumor of flexura hepatica without histology
+∞
6.2
6
*
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
+∞
6.2
6
*
8070/3-C44.5
ICD-O-3
Squamous cell carcinoma, NOS, of skin of trunk
+∞
6.2
6
*
8520/2-C50.9
ICD-O-3
Lobular carcinoma in situ, NOS, of breast, NOS
+∞
6.2
6
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
6.2
6
*
M90.7*C90.0
ICD-10 Finland
Pathological fracture in multiple myeloma
+∞
6.2
6
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
6.2
6
*
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
+∞
6.2
6
*
8020/3-C54.1
ICD-O-3
Carcinoma, undifferentiated, NOS, of endometrium
+∞
6.2
6
*
C18.10
ICD-10 Finland
Malignant tumor of the appendix without histology
+∞
6.2
6
*
C51.14
ICD-10 Finland
Basal cell carcinoma of labium minus
+∞
6.2
6
*
8010/3-C53.9
ICD-O-3
Carcinoma, NOS, of cervix uteri
+∞
6.2
6
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
6.2
6
*
8510/3-C50.9
ICD-O-3
Medullary carcinoma, NOS, of breast, NOS
+∞
6.2
6
*
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
+∞
6.2
6
*
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
+∞
6.2
6
*
C18.0
ICD-10 Finland
Malignant neoplasm: Caecum
+∞
6.2
6
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
6.2
6
*
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
+∞
6.2
6
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
6.2
6
*
JMA00
NOMESCO Finland
Partial splenectomy
+∞
6.2
6
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
6.2
6
*
JGB36
NOMESCO Finland
Wide excision of rectum
+∞
6.2
6
*
8090/3-C44.0
ICD-O-3
Basal cell carcinoma, NOS, of skin of lip, NOS
+∞
6.2
6
*
1749X
ICD-9 Finland
Malignant neoplasm of female breast, Breast (female), unspecified
+∞
6.2
6
*
SPAT1269
SPAT
Other puncture and/or drainage
3.7
6.2
25
68
WX702
NOMESCO Finland
Supraglottic ventilation device
1.6
6.2
167
1080
K30
ICD-10 Finland
Functional dyspepsia
0.7
6.2
302
3981
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.7
6.2
159
2328
UKB02
NOMESCO Finland
Retrograde ureteroscopy
3.3
6.2
29
89
JAA11
NOMESCO Finland
Laparoscopic biopsy or excision of lesion of abdominal wall
26.6
6.2
8
*
JFG96
NOMESCO Finland
Other operation on intestinal stoma or pouch
26.6
6.2
8
*
LAC96
NOMESCO Finland
Other excision or destruction of lesion of ovary
26.6
6.2
8
*
JFA83
NOMESCO Finland
Excision of lesion of colon
26.6
6.2
8
*
SPAT1167
SPAT
Insertion of urinary catheter
1.7
6.2
116
682
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
7.0
6.2
14
20
V252A
ICD-9 Finland
Contraceptive management, Sterilisation
0.8
6.2
349
4503
M01AC06
ATC
meloxicam; systemic, rectal
0.9
6.2
1564
17377
Z37.0
ICD-10 Finland
Single live birth
0.6
6.1
68
1196
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
3.6
6.1
25
69
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
2.1
6.1
66
320
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
5.7
6.1
16
28
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
7.6
6.1
13
17
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.1
6.1
64
309
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
0.5
6.1
55
1024
N13.0
ICD-10 Finland
Hydronephrosis with ureteropelvic junction obstruction
3.4
6.1
27
80
F45.8
ICD-10 Finland
Other somatoform disorders
0.6
6.1
101
1610
R03BB04
ATC
tiotropium bromide; inhalant
0.7
6.0
182
2583
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
0.6
6.0
118
1817
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
8.6
6.0
12
14
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
3.1
6.0
30
97
R07.3
ICD-10 Finland
Other chest pain
0.7
6.0
242
3277
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2246
8479
3.29
307.65
5.0
2.2
mmol/l
0.8
0.8
44.61
2133
7630
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1367
4406
3.51
307.65
1.8
2.0
g/l
0.2
0.2
2.33
1299
3988
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
3896
3459
21.97
307.65
9.9
1.5
u/ml
115.0
28.5
12.59
3833
3284
(4281824)
1722
418
52.25
307.65
1.2
1.1
—
—
—
0
0
(4035726)
2141
1833
15.67
307.65
1.5
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
357
168
21.87
307.65
2.6
1.1
u/ml
49.4
27.8
1.74
338
155
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
390
34
118.84
307.65
2.5
1.0
ug/l
4.1
2.2
0.72
266
19
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
452
349
13.48
307.65
1.1
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1915
3600
6.68
307.65
2.7
1.5
ug/l
6.8
9.1
0.27
1402
2699
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
4775
29562
2.62
307.65
8.4
3.5
umol/l
9.6
10.6
7.70
4587
27342
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
1827
1569
14.81
307.65
1.6
1.4
pmol/l
365.8
79.2
31.11
1779
1537
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
284
80
36.21
307.65
5.2
1.2
ng/l
116.2
84.1
0.55
129
20
(3024561) Albumin [Mass/volume] in Serum or Plasma
4736
26298
3.09
307.65
5.3
3.5
g/l
33.9
35.8
79.87
4527
23782
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
4981
26025
3.63
307.65
4.9
3.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
3613
17141
3.07
307.65
2.6
2.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
4168
22319
2.88
307.65
2.8
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2808
13027
2.79
307.65
2.6
2.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
2796
13941
2.55
306.03
4.6
3.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
152
11
138.56
298.07
1.2
1.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
4994
32855
2.48
289.20
16.1
6.5
e9/l
3.9
4.1
9.98
4395
27953
(3003396) Base excess in Arterial blood by calculation
1551
5903
2.99
285.92
5.5
5.8
mmol/l
0.9
1.5
6.20
1271
4632
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1544
5924
2.97
280.00
5.5
5.8
kpa
5.2
5.1
6.15
1487
5620
(3027801) Oxygen [Partial pressure] in Arterial blood
1541
5920
2.96
278.70
5.5
5.8
kpa
14.6
11.9
48.37
1484
5611
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
637
1345
4.99
277.02
2.5
1.9
u/ml
119.0
170.4
0.20
528
1067
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1315
4768
3.07
262.34
5.7
6.4
g/l
116.0
119.2
8.55
1280
4568
(3002256) Pathology report gross observation
1308
4957
2.93
239.55
1.3
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
202
128
15.91
232.09
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
2563
13809
2.25
220.16
1.4
1.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
2570
13920
2.24
217.38
4.3
3.2
%
95.2
93.0
4.61
2518
13473
(3008152) Bicarbonate [Moles/volume] in Arterial blood
948
3439
2.96
185.08
6.6
6.2
mmol/l
24.9
24.9
0.03
907
3174
(3016502) Oxygen saturation in Arterial blood
1241
5211
2.61
182.71
5.7
6.0
%
97.0
95.4
17.08
1198
4991
(40758558) Short blood count panel - Blood
2466
13902
2.11
181.78
12.0
4.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
955
3579
2.86
175.17
4.2
4.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
591
1668
3.69
173.49
4.1
4.0
mmol/l
3.8
3.8
0.41
570
1580
(3032080) INR in Blood by Coagulation assay
3611
23720
1.96
170.03
7.9
8.4
inr
1.2
1.2
5.10
1032
6588
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
478
1211
4.07
163.38
1.8
2.5
g/l
3.8
3.5
3.17
463
1134
(3023487) Leukocytes [#/volume] in Peritoneal fluid
156
118
13.24
162.29
1.3
2.3
e6/l
6782.8
1533.3
0.61
80
78
(3014007) Fractional oxyhemoglobin in Arterial blood
840
3059
2.91
161.86
6.2
7.1
%
94.8
93.5
9.26
840
3048
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
246
351
7.09
159.89
3.8
1.2
ug/l
16.4
2.9
1.87
137
282
(40768806) Pleura Pathology biopsy report
218
284
7.74
153.55
1.4
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
2336
13587
2.00
152.81
1.6
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
3299
21562
1.90
152.32
4.4
2.1
mmol/l
2.4
2.4
0.89
2968
17763
(3000991) Gas panel - Venous blood
995
4122
2.58
148.61
6.2
6.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
134
96
13.95
143.81
1.3
2.2
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
138
105
13.14
143.02
1.3
1.9
e6/l
9097.9
38989.6
0.67
53
47
(3033799) Differential panel - Peritoneal fluid
131
93
14.07
141.31
1.2
2.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1347
6538
2.25
140.51
6.9
5.3
mmol/l
104.1
103.9
0.73
1321
6384
(3020891) Body temperature
659
2263
3.04
140.34
4.5
4.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
1438
7224
2.18
137.48
2.0
1.9
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
1012
4446
2.43
132.43
5.5
5.3
mmol/l
1.2
1.4
3.63
985
4286
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
5895
47529
2.02
132.19
9.7
5.4
u/l
86.3
76.0
26.41
5615
43616
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
336
770
4.44
130.74
2.3
1.9
u/ml
240.8
73.9
0.98
304
688
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
4051
29169
1.79
128.75
5.7
4.6
mmol/l
1.2
1.2
68.13
3738
25600
(3013826) Glucose [Moles/volume] in Serum or Plasma
4721
35660
1.81
126.72
5.0
3.9
mmol/l
6.8
6.7
5.08
4514
32924
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
4372
32504
1.77
121.40
6.3
5.1
mmol/l
1.2
1.2
80.60
3722
27140
(3020779) Urea [Moles/volume] in Serum or Plasma
909
4016
2.39
116.63
7.2
6.0
mmol/l
8.8
10.1
5.90
869
3779
(3026008) Bacteria identified in Urine by Culture
3463
24304
1.74
115.70
3.9
3.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
464
1462
3.26
113.80
2.7
3.1
u/ml
0.4
0.4
0.73
239
878
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
441
1352
3.34
113.06
1.8
2.0
%
91.3
94.4
1.93
423
1220
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
426
1288
3.39
111.64
1.8
2.3
%
215.3
182.7
10.28
414
1206
(3031040) Bacteria [#/volume] in Urine by Automated count
5461
43995
1.81
108.18
6.0
5.1
e6/l
1456.0
2675.2
1.64
126
555
(3009261) Glucose [Presence] in Urine by Test strip
4342
32950
1.70
104.78
5.4
4.3
estimate
0.0
0.0
2.04
826
5612
(3021601) Nitrite [Presence] in Urine by Test strip
4300
32637
1.69
102.82
7.3
5.6
estimate
0.0
0.0
1.34
812
5549
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
73
29
24.97
102.59
1.1
1.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1050
5230
2.13
99.92
4.3
2.8
u/l
244.3
242.7
0.15
1004
4807
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1469
8437
1.88
92.63
2.2
1.9
s
29.1
29.5
1.29
1437
8139
(3003434) Protein [Mass/volume] in Pleural fluid
211
441
4.81
91.84
1.3
1.5
g/l
37.7
28.3
17.68
194
373
(40768793) Breast Pathology biopsy report
257
630
4.11
91.37
1.3
1.2
—
—
—
0
0
(3036489) Thrombin time
508
1911
2.73
90.44
1.7
1.8
s
21.3
21.5
0.35
475
1639
(3023199) Leukocytes [#/volume] in Pleural fluid
198
402
4.94
89.18
1.3
1.5
e6/l
1384.7
2145.7
1.01
136
297
(3020630) Protein [Mass/volume] in Serum or Plasma
958
4819
2.09
88.12
4.7
1.5
g/l
64.9
66.7
10.89
891
4219
(3028308) Erythrocytes [#/volume] in Pleural fluid
183
353
5.20
87.42
1.3
1.5
e6/l
29163.5
47921.7
0.45
97
207
(3002582) Erythrocytes [#/volume] in Urine
2578
17730
1.65
85.12
3.3
3.1
e6/l
61.1
75.6
0.46
1962
13199
(3018095) Leukocytes [#/volume] in Urine
3018
21708
1.61
82.43
4.8
3.6
e6/l
156.1
130.0
0.57
2120
14560
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
108
139
7.73
76.80
2.2
2.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
857
4389
2.04
74.37
1.7
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2574
18149
1.60
74.31
5.3
2.5
u/l
35.7
31.4
0.74
2460
16979
(3012441) Differential panel - Pleural fluid
159
316
5.03
73.42
1.4
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
2379
16524
1.61
72.79
3.2
3.0
e6/l
0.6
0.4
1.53
1780
12235
(36304419) Bacteria [Presence] in Urine
2323
16088
1.61
71.71
3.2
3.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
457
1865
2.50
68.60
2.0
1.8
ug/l
3.4
2.4
0.66
410
1572
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
364
1343
2.75
66.99
1.6
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
1140
6717
1.79
63.80
1.8
1.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
149
316
4.71
63.73
1.4
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
2644
19372
1.53
61.35
3.6
3.1
ph
7.4
7.4
0.01
471
3254
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1016
5863
1.81
60.74
3.6
3.2
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
134
283
4.72
57.63
1.2
1.3
u/l
435.4
254.9
3.67
129
260
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1148
7022
1.72
55.69
4.6
4.2
mmol/l
1.0
1.0
0.83
1048
6331
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
5786
62078
0.63
55.63
4.2
4.6
mmol/l
1.6
1.6
15.12
5151
56463
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
539
2577
2.14
55.61
7.5
7.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
5852
62619
0.63
55.43
4.2
4.7
mmol/l
4.8
4.8
0.33
5240
57277
(3036782) Glucose [Moles/volume] in Pleural fluid
135
300
4.48
54.54
1.3
1.3
mmol/l
5.6
6.9
6.02
129
273
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
6031
64037
0.62
54.04
4.8
5.3
mmol/l
2.8
2.8
0.41
5367
58374
(3000850) Epithelial cells [#/volume] in Urine
1815
12521
1.56
54.03
2.6
2.5
e6/l
8.3
7.5
1.05
1579
10792
(3026692) Albumin [Mass/volume] in Peritoneal fluid
74
93
7.89
53.70
1.0
1.4
g/l
20.4
11.9
9.35
68
63
(3011397) Hemoglobin [Presence] in Urine by Test strip
2235
16208
1.51
52.50
5.3
4.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2643
19846
1.48
52.16
3.3
2.2
u/l
55.3
58.3
2.31
2466
17907
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
176
499
3.52
50.81
2.6
1.9
u/ml
6.1
559.2
0.89
171
480
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
68
84
8.02
50.06
1.2
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
3979
32480
1.43
49.38
5.6
4.2
estimate
0.0
0.0
0.50
812
5549
(40761535) Cells panel - Urine sediment
944
5663
1.73
48.64
4.3
3.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1374
9150
1.58
46.81
3.0
2.7
e6/l
4.6
5.0
0.30
709
4715
(3029937) Albumin [Presence] in Urine by Test strip
2351
17581
1.46
45.94
5.8
4.7
estimate
0.0
0.0
0.05
793
5607
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1389
9316
1.57
45.77
1.8
1.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1510
10341
1.54
45.28
2.9
2.6
e6/l
1.7
1.4
1.32
831
5860
(3026782) Osmolality of Urine
1650
11573
1.51
44.12
2.9
2.7
mosm/kgh2o
503.3
504.0
0.04
1422
9614
(3039000) Anion gap in Blood
290
1180
2.47
43.64
4.8
5.7
mmol/l
11.0
11.1
0.36
262
1053
(3018572) Chloride [Moles/volume] in Blood
290
1181
2.47
43.56
4.8
5.7
mmol/l
105.4
104.4
3.32
262
1054
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
258
994
2.61
43.52
1.2
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1314
8804
1.57
43.22
8.3
6.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
5197
45066
1.43
42.73
6.5
4.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
249
957
2.61
42.21
1.7
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
5571
59585
0.68
41.63
6.0
6.0
mmol/mol
40.5
39.8
6.19
5051
54492
(3021447) Carbon dioxide [Partial pressure] in Venous blood
840
5158
1.68
39.21
3.5
3.3
kpa
5.8
5.9
2.20
817
5011
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
980
6264
1.62
39.03
2.6
2.1
umol/l
7.9
6.3
1.45
833
5239
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
66
105
6.22
38.72
1.3
1.3
%
66.7
58.9
0.96
56
82
(3002032) Base excess in Venous blood by calculation
835
5143
1.67
38.49
3.5
3.3
mmol/l
2.1
2.2
0.12
688
4267
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
576
3196
1.83
38.34
1.5
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
275
1174
2.35
37.21
2.9
2.0
u/l
464.2
4680.1
5.78
119
505
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
5625
59772
0.70
36.48
3.8
4.1
mmol/l
1.3
1.3
16.30
4968
53774
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1721
12580
1.45
36.29
3.3
2.3
mmol/l
2.5
2.5
25.18
1536
10729
(3021589) Normoblasts [#/volume] in Blood
3261
26591
1.36
35.92
12.2
8.4
e9/l
0.0
0.0
1.03
2655
21706
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
987
6457
1.58
35.42
1.7
1.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
843
5327
1.63
34.94
2.2
2.2
u/l
34.1
35.4
0.26
710
4453
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
52
73
7.04
34.32
12.4
1.3
u/l
43.6
46.2
0.09
35
30
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1130
7674
1.53
34.19
2.4
2.5
%
20.1
21.2
2.08
936
6346
(3035880) pH of Pleural fluid
83
183
4.50
33.97
1.2
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
3679
30723
1.35
33.95
6.0
5.5
e9/l
1.7
1.9
2.98
3162
26724
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
205
800
2.56
33.72
1.3
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
939
6147
1.57
33.47
2.5
2.1
%
1.9
1.8
1.50
835
5267
(3006315) Basophils [#/volume] in Blood
3604
30063
1.34
33.21
6.0
5.5
e9/l
0.0
0.0
11.51
3053
25642
(3013115) Eosinophils [#/volume] in Blood
3710
31088
1.34
33.13
6.1
5.6
e9/l
0.2
0.2
22.45
3184
26961
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
975
6455
1.56
33.05
1.7
1.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
3584
29894
1.34
32.94
6.0
5.5
e9/l
0.6
0.6
0.92
3042
25517
(3012544) pH of Venous blood
833
5341
1.60
32.39
3.5
3.3
ph
7.4
7.4
—
7
21
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1845
13951
1.40
31.41
1.7
1.7
mg/l
1.9
1.1
11.54
1511
10595
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1188
8317
1.48
30.73
2.3
2.3
g/l
2.2
2.4
17.97
1089
7540
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
752
4770
1.61
30.50
4.0
2.3
ml/min/173m2
60.0
63.0
1.65
345
1914
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
436
2403
1.83
29.53
4.2
4.2
%
1.7
1.6
1.89
403
2256
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
6694
62114
1.55
29.37
20.1
12.7
mg/l
32.5
20.6
114.01
5882
48100
(3019069) Monocytes/100 leukocytes in Blood
3335
27816
1.32
29.34
6.2
6.0
%
8.6
8.4
2.47
3117
25578
(42870588) Differential panel, method unspecified - Blood
2507
20086
1.34
29.11
5.8
5.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
1278
9177
1.44
28.79
2.4
2.4
umol/l
11.7
12.6
3.13
1183
8297
(3002030) Lymphocytes/100 leukocytes in Blood
3397
28461
1.32
28.70
6.0
5.8
%
25.5
28.7
42.86
3160
26012
(3044889) 12 lead EKG panel
5010
44323
1.33
28.57
4.2
3.8
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
694
4392
1.61
28.33
3.2
2.9
kpa
4.4
4.4
0.10
672
4264
(3007930) Methemoglobin/Hemoglobin.total in Blood
427
2380
1.81
27.87
4.3
4.3
%
0.9
0.9
0.13
395
2232
(3047181) Lactate [Moles/volume] in Blood
334
1730
1.94
27.41
4.9
5.0
mmol/l
1.3
1.3
0.16
298
1526
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
40
55
7.18
26.90
1.2
1.4
ug/l
775.7
43.6
0.45
17
33
(3017181) Myelocytes/100 leukocytes in Blood
735
4786
1.56
26.51
3.2
3.8
%
1.4
0.7
5.28
296
919
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
565
3469
1.65
26.00
1.6
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
6023
62624
0.72
25.90
4.9
4.9
mmol/l
6.0
5.9
12.85
5376
56564
(3006504) Eosinophils/100 leukocytes in Blood
3289
27679
1.30
25.89
5.9
5.7
%
2.5
2.9
20.89
3064
25301
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1433
18119
0.72
25.36
1.6
1.6
mmol/l
1.5
1.3
8.23
1182
15051
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
5860
61147
0.73
25.20
5.6
5.5
mu/l
2.1
2.0
0.07
5306
55795
(3022096) Basophils/100 leukocytes in Blood
3196
26862
1.29
25.14
5.9
5.8
%
0.6
0.7
10.64
2979
24570
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
138
513
2.67
25.13
2.4
1.3
nmol/l
0.2
0.4
4.54
93
382
(3049717) Cytology report of Urine Cyto stain
280
1414
1.98
24.75
2.4
1.8
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
164
673
2.43
24.34
2.4
2.8
%
1.9
1.1
1.90
139
518
(3018010) Neutrophils/100 leukocytes in Blood
3322
28177
1.28
23.90
5.8
5.6
%
59.2
56.9
17.28
3098
25857
(3009214) Lutropin [Units/volume] in Serum or Plasma
150
600
2.49
23.54
1.5
1.2
u/l
24.3
17.1
4.36
131
479
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
43
74
5.74
23.37
5.5
1.4
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
48
93
5.10
22.97
1.3
1.3
%
1.3
2.2
0.38
42
76
(40761536) Microorganisms panel - Urine sediment
753
5093
1.50
22.66
6.7
4.3
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
81
236
3.40
22.62
1.3
1.5
u/l
10.1
13.2
4.02
76
225
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
291
1540
1.89
22.41
2.1
2.9
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
141
561
2.50
22.40
6.6
6.3
mg/l
13.2
12.6
0.66
136
497
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
463
2809
1.66
22.28
1.6
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1632
12676
1.34
22.19
4.9
4.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
464
2827
1.65
21.96
2.8
2.4
e6/l
0.2
0.3
1.70
449
2725
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2953
24893
1.27
21.56
5.8
4.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
687
4608
1.51
21.47
2.5
2.2
e9/l
72.3
71.5
0.18
461
3445
(3026726) Creatinine [Moles/volume] in Specimen
20
16
12.31
19.90
1.1
4.2
umol/l
921.1
300.0
0.36
20
16
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
447
2790
1.61
19.19
2.7
2.6
%
1.3
1.2
0.95
447
2775
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
39
74
5.20
19.14
1.5
1.5
%
17.8
23.2
0.59
31
62
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
398
2418
1.65
19.04
3.9
3.6
mmol/l
24.3
24.5
0.51
347
2139
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
310
1760
1.76
19.03
1.3
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
543
3563
1.54
18.76
3.0
3.1
g/l
121.5
127.5
9.21
536
3477
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
438
2741
1.61
18.60
2.7
2.5
%
0.7
0.7
0.54
420
2609
(3027273) Bicarbonate [Moles/volume] in Venous blood
457
2900
1.58
18.30
3.2
3.0
mmol/l
25.4
25.7
0.74
449
2819
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
220
1138
1.93
18.21
3.8
2.8
mg/l
1.4
1.6
2.69
206
1018
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
99
391
2.51
16.10
1.6
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1818
14864
1.27
15.97
5.4
4.8
kg/l
1.0
1.0
0.72
191
2322
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
5115
53574
0.80
15.95
4.8
4.6
pmol/l
15.1
14.9
4.38
4629
48488
(3022217) INR in Platelet poor plasma by Coagulation assay
1080
8246
1.34
15.94
20.1
26.2
inr
1.3
1.3
0.48
119
1138
(3021440) Promyelocytes/100 leukocytes in Blood
652
4631
1.42
15.02
3.3
3.8
%
0.3
0.1
6.19
238
862
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
77
279
2.73
14.91
1.8
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
112
486
2.28
14.82
2.3
2.9
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1919
15950
1.24
14.34
2.2
2.3
mg/l
3.2
3.0
2.92
1625
13547
(3037121) Protein [Mass/volume] in Urine
317
1966
1.61
14.01
4.6
2.4
g/l
0.2
0.3
2.49
153
493
(3035637) Corticotropin [Mass/volume] in Plasma
119
544
2.17
13.90
1.5
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
983
12195
0.76
13.82
1.2
1.3
u/ml
12.9
14.7
0.32
387
4493
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
307
1901
1.61
13.67
2.0
2.2
ug/l
564.0
635.4
0.13
289
1753
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2315
19718
1.22
13.57
2.9
2.9
ng/l
1596.4
1322.1
1.37
2020
16742
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1045
12720
0.78
12.55
1.3
1.3
iu/ml
49.4
36.1
0.98
336
4073
(3002179) Metamyelocytes/100 leukocytes in Blood
608
4424
1.38
12.13
3.2
3.6
%
0.8
0.6
1.02
169
692
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
30
68
4.35
12.02
1.2
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
236
3688
0.62
11.97
1.3
1.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
44
132
3.29
11.90
6.3
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
139
717
1.92
11.75
3.3
4.7
iu/ml
220.7
530.0
1.55
15
92
(3025159) Blasts/100 leukocytes in Blood
607
4439
1.37
11.74
3.3
3.8
%
0.0
0.2
0.86
196
764
(3019550) Sodium [Moles/volume] in Serum or Plasma
6852
65353
1.35
11.71
25.3
14.9
mmol/l
139.2
139.8
50.83
6741
63399
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
330
2176
1.51
11.19
1.8
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2825
24866
1.19
11.03
3.7
3.7
ng/l
33.7
61.7
1.42
2085
16771
(3018738) Hemoglobin F/Hemoglobin.total in Blood
14
16
8.61
10.88
1.1
4.4
—
18.4
—
0
6
(3017143) Hepatitis C virus Ab [Presence] in Serum
652
4884
1.34
10.79
1.4
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
687
8677
0.76
10.79
4.2
4.8
%
32.5
33.8
2.48
421
5622
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
23
46
4.92
10.70
1.2
1.3
%
23.3
12.8
—
8
22
(3023103) Potassium [Moles/volume] in Serum or Plasma
6856
65509
1.33
10.60
25.2
15.0
mmol/l
3.9
3.9
0.61
6740
63419
(3002385) Erythrocyte distribution width [Ratio]
5424
50535
1.20
10.58
27.6
15.2
%
14.2
13.7
99.88
5337
49279
(40757494) Bilirubin.total [Moles/volume] in Blood
75
321
2.31
10.38
1.9
1.9
umol/l
16.3
14.0
—
9
35
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
10
0
+∞
10.35
1.0
0.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
720
5524
1.31
10.07
2.4
2.4
ug/l
4.0
5.8
5.58
613
4613
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
688
5253
1.32
9.97
3.4
2.8
mmol/l
1.2
1.2
0.10
601
4368
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
106
529
1.98
9.94
1.5
2.4
u/ml
9974.0
1221.7
—
5
26
(40768441) Liver Pathology biopsy report
68
286
2.35
9.81
1.2
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
296
1967
1.50
9.71
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
292
1935
1.50
9.71
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
294
1956
1.50
9.60
1.2
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
57
226
2.49
9.37
1.9
1.9
%
14.7
14.2
0.08
28
108
(3052851) Hemolysis interference index of Serum or Plasma
272
1791
1.51
9.34
3.2
3.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
196
1201
1.62
9.23
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
196
1201
1.62
9.23
1.3
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
55
217
2.50
9.14
2.0
2.0
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
15
23
6.42
9.13
1.0
1.7
%
9.3
15.0
—
10
8
(1616796) Gas panel - Central venous blood
182
1105
1.63
8.91
3.2
3.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
364
2560
1.42
8.91
8.6
7.1
mmol/l
24.4
24.7
0.66
338
2324
(3010421) pH of Blood
221
1406
1.56
8.90
3.5
3.4
ph
7.4
7.4
0.01
172
1145
(3021879) Hepatitis B virus core Ab [Presence] in Serum
418
3013
1.38
8.86
1.3
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
339
2359
1.43
8.80
1.9
1.8
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
57
233
2.41
8.80
1.9
1.9
%
73.1
73.8
0.16
57
222
(3001019) Free T4 and TSH panel - Serum or Plasma
181
2767
0.63
8.40
1.8
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
59
252
2.31
8.29
2.9
4.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
28
80
3.45
8.25
2.1
2.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
178
1099
1.61
8.18
1.6
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
85
425
1.98
8.01
1.1
1.1
—
—
—
0
0
(44790047)
89
458
1.92
7.73
1.5
1.3
—
—
—
0
0
(44790049)
89
458
1.92
7.73
1.5
1.3
—
—
—
0
0
(44790048)
89
458
1.92
7.73
1.5
1.3
—
—
—
0
0
(44806118)
89
458
1.92
7.73
1.5
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
114
637
1.77
7.64
1.4
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2826
30186
0.87
7.43
2.3
2.3
nmol/l
78.5
80.7
3.91
2505
26423
(3021901) Oxygen saturation in Capillary blood
149
905
1.63
7.36
2.7
2.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
4098
37840
1.14
7.23
3.7
2.9
u/l
54.4
40.7
13.18
3785
34508
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
158
985
1.59
7.03
1.4
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
6175
58761
1.18
7.03
21.6
11.6
ml/min/173m2
76.5
76.4
0.05
5356
46744
(40767503) Oxygen content in Capillary blood by calculation
176
1130
1.54
6.90
2.6
2.5
%
15.5
16.1
1.28
101
561
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
169
1076
1.56
6.88
4.0
3.4
%
60.5
57.7
2.05
169
1076
(3014891) Appearance of Pleural fluid
22
61
3.55
6.81
1.5
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
163
1035
1.56
6.73
1.4
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
308
4083
0.73
6.71
1.2
1.3
au/ml
34.2
50.3
0.87
11
160
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
344
4482
0.74
6.68
2.3
2.4
au/ml
26.6
30.0
0.14
16
215
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
61
292
2.06
6.56
4.4
1.2
u/ml
120.3
323.7
1.93
15
74
(3022475) Manganese [Moles/volume] in Blood
16
36
4.37
6.53
1.3
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1892
16683
1.15
6.40
5.3
3.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
132
812
1.61
6.26
1.3
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
740
6033
1.23
6.22
1.4
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
131
2006
0.64
6.22
1.6
1.6
mg/l
5.4
3.2
1.01
98
1422
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
9
5
17.70
6.20
1.0
1.4
umol/l
2603.3
1191.3
—
9
5
(1002224) Polysomnography panel
127
1956
0.63
6.19
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
323
2380
1.35
6.06
1.4
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1801
19636
0.87
6.05
3.1
3.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1353
15054
0.86
6.00
1.2
1.3
u/ml
1.0
1.5
2.21
384
3961
(3013139) Helicobacter pylori Ag [Presence] in Stool
411
5143
0.77
5.97
1.2
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
63
319
1.95
5.84
1.9
2.1
e9/l
1.1
1.2
0.26
50
169
(3011544) Albumin [Mass/volume] in Pleural fluid
14
31
4.44
5.82
1.1
1.2
g/l
20.5
14.6
1.57
14
23
(3000492) Spirometry study
431
5341
0.78
5.79
1.5
1.5
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
26
89
2.88
5.79
2.2
1.8
—
—
—
0
0
(3012501) Base excess in Blood by calculation
176
1178
1.48
5.74
3.6
3.6
mmol/l
2.8
2.7
0.19
118
823
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
405
3115
1.29
5.63
4.0
3.2
mmol/l
1.9
2.2
0.54
305
2390
(3015235) Bicarbonate [Moles/volume] in Capillary blood
187
1275
1.45
5.56
3.3
2.9
mmol/l
25.0
25.5
0.82
174
1119
(3006184) Hemoglobin [Mass/volume] in Capillary blood
196
1355
1.43
5.43
2.4
2.1
g/l
124.7
127.4
0.98
154
973
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
836
9600
0.84
5.41
1.4
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
326
2451
1.32
5.37
1.7
1.6
g/l
1.7
1.6
1.18
257
2078
(3009343) pH of Capillary blood
416
3235
1.28
5.32
4.0
3.3
ph
7.4
7.4
0.09
76
420
(3019832) Treponema pallidum Ab [Presence] in Serum
229
3057
0.73
5.28
1.4
1.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
555
4476
1.24
5.19
4.3
3.0
pmol/l
4.5
4.4
0.21
499
3877
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
179
1228
1.44
5.18
1.7
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
78
443
1.74
5.08
2.3
2.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
119
754
1.56
5.06
1.1
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
113
709
1.57
5.02
1.3
1.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
418
3278
1.27
5.01
4.0
3.3
kpa
5.2
5.2
0.73
393
2982
(3017354) Segmented neutrophils/100 leukocytes in Blood
80
461
1.71
4.96
3.0
2.6
%
61.4
59.8
0.23
56
307
(3044242) Glucose [Moles/volume] in Arterial blood
51
255
1.97
4.96
2.5
2.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
29
115
2.48
4.92
2.0
1.8
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
32
133
2.37
4.92
2.6
2.5
%
36.9
47.6
1.82
16
53
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
10
19
5.18
4.92
1.1
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
103
638
1.59
4.85
1.3
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
454
5473
0.80
4.83
1.1
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
687
5715
1.20
4.72
3.0
1.8
nmol/l
408.5
371.6
4.31
635
5128
(3004716) Salmonella sp identified in Stool by Organism specific culture
382
2999
1.27
4.57
1.4
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
101
633
1.58
4.55
4.1
7.7
mmol/l
7.5
7.5
0.03
83
519
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
97
603
1.59
4.52
1.3
1.3
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
29
120
2.38
4.52
2.0
1.8
%
7.2
8.3
0.39
29
115
(3037522) Nuclear Ab [Titer] in Serum
811
9197
0.85
4.51
1.4
1.4
titre
571.2
618.2
0.32
171
2216
(3045142) Bone marrow Pathology biopsy report
67
381
1.73
4.40
1.2
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
322
3975
0.79
4.25
1.7
1.7
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
28
118
2.34
4.21
1.8
2.0
%
29.9
26.2
0.84
28
113
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
116
764
1.50
4.21
1.6
1.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
9
284
0.31
4.18
1.3
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
162
1139
1.41
4.18
1.6
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
99
634
1.54
4.10
2.8
3.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
244
1841
1.31
4.02
5.1
5.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
10
23
4.28
3.98
1.0
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
780
6659
1.17
3.98
1.3
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
67
393
1.68
3.98
1.3
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
141
1936
0.71
3.96
1.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
78
478
1.61
3.91
1.1
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
50
271
1.82
3.90
1.3
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
50
271
1.82
3.90
1.3
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
66
388
1.68
3.89
1.3
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
42
753
0.55
3.85
1.5
1.5
—
—
—
0
0
(4010399)
424
5021
0.82
3.84
1.3
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
436
3546
1.22
3.84
1.3
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
103
676
1.50
3.83
1.1
1.3
u/ml
126.5
119.0
0.49
26
143
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
51
280
1.80
3.82
1.6
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
51
863
0.58
3.81
1.5
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
4830
49056
0.91
3.80
4.0
4.4
mm/h
17.5
13.1
50.85
4387
45070
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
109
727
1.48
3.76
1.3
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3387
34949
0.91
3.73
2.6
2.7
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
196
1451
1.34
3.71
3.5
3.6
mg/l
30.1
23.9
1.32
139
926
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
588
6734
0.85
3.70
1.6
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
193
1427
1.34
3.69
1.2
1.3
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
29
132
2.16
3.69
2.1
2.1
u/ml
3590.4
99538.4
—
7
16
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
211
2691
0.76
3.66
1.5
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
97
636
1.51
3.65
2.0
1.6
pg
31.9
32.1
0.15
97
630
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
418
4928
0.82
3.64
1.5
1.6
%
1.4
1.4
0.55
356
4249
(3003181) Sodium [Moles/volume] in Urine
184
1356
1.34
3.61
1.3
1.4
mmol/l
59.3
61.9
0.41
141
1093
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
89
576
1.52
3.57
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
39
695
0.55
3.54
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
39
695
0.55
3.54
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
39
694
0.55
3.52
1.4
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
27
122
2.18
3.51
1.6
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
39
693
0.55
3.51
1.4
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
101
675
1.48
3.48
1.4
1.3
u/l
45.6
33.8
2.53
87
519
(40765096) Chromosome analysis panel by Banding
16
57
2.76
3.40
1.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
32
597
0.52
3.40
1.5
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
94
1333
0.69
3.24
1.4
1.5
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
16
59
2.67
3.20
1.2
1.2
ug/l
98.5
112.6
—
9
38
(3000060) B lymphocytes [#/volume] in Blood
20
83
2.37
3.17
1.8
2.2
e6/l
232.0
133.2
—
10
56
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
63
388
1.60
3.17
1.3
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
63
388
1.60
3.17
1.3
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
63
388
1.60
3.17
1.3
1.3
—
—
—
0
0
(4094501)
124
1666
0.73
3.13
1.1
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
32
579
0.54
3.10
1.4
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
123
874
1.39
3.09
2.2
2.5
umol/l
34.2
31.3
0.52
103
737
(3005033) Fetal Nuchal fold Thickness US
32
577
0.54
3.07
1.4
1.4
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
9
20
4.43
3.06
1.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
172
2190
0.77
3.01
1.4
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
152
1127
1.33
2.93
1.7
1.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
63
399
1.56
2.85
2.3
1.9
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
9
6.55
2.83
1.0
1.0
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
232
2822
0.80
2.80
1.1
1.1
u/ml
0.9
1.7
—
5
43
(3024928) Oxygen saturation in Venous blood
148
1103
1.32
2.78
2.7
3.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
8
18
4.37
2.75
6.8
1.7
umol/l
0.3
0.6
—
8
9
(3028026) IgM [Mass/volume] in Serum or Plasma
381
3171
1.19
2.72
1.7
1.5
g/l
1.2
1.3
0.43
343
2855
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
345
4019
0.84
2.71
1.3
1.3
—
—
—
0
0
(3019977) pH of Arterial blood
47
281
1.65
2.71
3.4
2.5
ph
7.4
7.4
0.06
20
97
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2831
29169
0.93
2.70
2.0
2.0
pmol/l
94.9
99.4
4.89
1472
13261
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
23
110
2.06
2.66
1.3
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
40
231
1.71
2.63
2.0
2.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
336
3905
0.84
2.58
1.3
1.3
u/ml
478.3
183.3
0.48
307
3580
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
10
32
3.07
2.56
1.1
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
12
43
2.74
2.55
1.1
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
11
38
2.85
2.50
1.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
6642
64410
1.12
2.39
20.3
12.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
25
129
1.91
2.38
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
89
630
1.39
2.37
2.0
3.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
170
1323
1.27
2.36
1.2
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
137
1037
1.30
2.36
1.2
1.2
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
30
165
1.79
2.35
1.1
1.3
—
194425.0
—
0
6
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
7
17
4.05
2.32
1.9
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
42
643
0.64
2.23
6.2
3.2
%
13.3
13.3
0.06
42
634
(43055442) Apixaban [Mass/volume] in Serum or Plasma
19
91
2.05
2.22
1.3
1.5
ug/l
52.4
129.0
5.47
13
77
(3010726) Horse dander IgE Ab [Units/volume] in Serum
46
688
0.65
2.20
1.0
1.1
u/ml
2.3
1.4
—
10
154
(3023323) Follitropin [Units/volume] in Serum or Plasma
262
2155
1.20
2.19
1.4
1.3
iu/l
40.5
35.1
1.48
216
1891
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
38
229
1.63
2.18
1.3
1.4
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
29
482
0.59
2.18
1.1
1.0
ng/l
43.3
47.5
0.27
19
317
(3008401) Mugwort IgE Ab [Units/volume] in Serum
54
780
0.68
2.17
1.1
1.1
u/ml
0.7
0.9
0.23
16
298
(3016038) Potassium [Moles/volume] in Urine
73
509
1.41
2.15
1.2
1.1
mmol/l
32.5
33.4
0.12
61
413
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
27
455
0.58
2.14
1.1
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
6935
68745
0.88
2.14
34.4
18.9
e12/l
4.2
4.4
179.97
6735
66208
(3010813) Leukocytes [#/volume] in Blood
6936
68752
0.88
2.13
34.4
18.9
e9/l
6.7
6.6
3.21
6737
66207
(3010503) CD19 cells [#/volume] in Blood
35
208
1.66
2.13
2.0
2.2
e9/l
0.1
0.2
0.85
35
197
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
29
478
0.59
2.12
1.1
1.0
ng/l
738.1
692.2
0.23
19
298
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
132
1650
0.78
2.10
1.4
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
6937
68757
0.88
2.10
34.6
19.0
g/l
125.3
132.1
305.14
6858
67445
(3003888) Timothy IgE Ab [Units/volume] in Serum
57
809
0.69
2.10
1.0
1.1
u/ml
4.3
2.5
0.43
18
373
(3032352) Blasts [#/volume] in Cerebral spinal fluid
9
30
2.95
2.10
1.4
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
6935
68738
0.88
2.10
34.3
18.8
fl
91.5
91.2
5.95
6851
67415
(3035941) MCH [Entitic mass]
6935
68735
0.88
2.08
34.2
18.8
pg
30.1
30.2
0.96
6849
67414
(3017446) Testosterone [Moles/volume] in Serum or Plasma
41
256
1.58
2.06
1.6
1.3
nmol/l
0.8
1.4
2.25
33
209
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
38
233
1.61
2.06
1.3
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
184
2209
0.81
2.06
2.0
1.8
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
29
473
0.60
2.04
1.1
1.0
ng/l
330.1
369.7
0.29
19
315
(3007164) IgA [Mass/volume] in Serum or Plasma
1148
12146
0.92
2.04
1.4
1.3
g/l
2.2
2.4
2.01
640
6661
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
61
417
1.44
2.02
1.4
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
123
1540
0.78
2.00
1.1
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
28
458
0.60
2.00
1.1
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
76
542
1.38
1.99
1.3
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
131
1620
0.79
1.94
1.4
1.3
u/ml
5.7
4.7
—
8
123
(3007461) Platelets [#/volume] in Blood
6935
68709
0.89
1.93
34.4
18.9
e9/l
263.9
260.9
2.97
6755
66442
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
94
698
1.33
1.92
1.2
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
149
1808
0.81
1.87
1.1
1.1
u/ml
2.8
8.0
1.79
20
169
(3009466) Valproate [Moles/volume] in Serum or Plasma
56
778
0.71
1.87
5.1
4.7
umol/l
350.2
368.5
0.49
48
658
(3017569) Oxygen content in Arterial blood
40
255
1.54
1.87
2.7
2.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
257
2960
0.85
1.86
1.3
1.3
u/ml
0.7
0.8
0.08
37
271
(21494434) Karyotype in Bone marrow
55
376
1.44
1.84
1.1
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1633
15158
1.07
1.83
2.6
2.1
umol/l
4650.3
5299.2
0.22
1379
12654
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
11
232
0.47
1.82
2.0
2.4
—
33.1
—
0
14
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
310
3509
0.86
1.81
1.1
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1319
13806
0.93
1.81
1.8
1.8
nmol/l
1267.3
1194.2
1.84
989
10183
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
17
309
0.54
1.81
1.2
1.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
12
52
2.27
1.80
1.2
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
65
461
1.39
1.79
1.3
1.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
182
2152
0.83
1.79
1.3
1.3
u/ml
21.5
48.5
0.75
11
140
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
65
463
1.38
1.75
1.3
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
462
4049
1.13
1.75
2.7
2.5
g/l
10.1
10.5
1.62
422
3684
(3034860) Kappa light chains.free [Mass/volume] in Serum
227
1892
1.18
1.71
2.8
1.6
mg/l
42.5
39.6
0.27
185
1542
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
226
1883
1.18
1.71
2.8
1.6
mg/l
42.9
34.0
0.41
184
1528
(3021960) Folate [Moles/volume] in Serum or Plasma
1749
16314
1.07
1.70
1.5
1.5
nmol/l
21.2
21.9
1.08
1530
13545
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
32
485
0.65
1.70
1.2
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
107
825
1.28
1.69
1.3
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
72
943
0.75
1.69
1.4
1.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
19
327
0.57
1.69
1.5
1.5
promille
1.0
1.1
0.06
13
241
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
132
1600
0.81
1.68
1.7
1.8
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
34
215
1.56
1.67
1.1
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
12
54
2.19
1.67
11.9
11.2
mmol/l
4.5
4.7
0.16
12
54
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
69
904
0.75
1.63
1.1
1.1
u/ml
0.5
0.9
0.70
19
323
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
105
812
1.27
1.63
1.3
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
25
147
1.67
1.63
2.5
2.5
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
14
68
2.02
1.62
1.0
1.0
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
43
608
0.69
1.62
1.0
1.1
u/ml
10.0
3.2
0.53
12
220
(3025468) Yersinia sp identified in Specimen by Organism specific culture
105
813
1.27
1.62
1.3
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
21
118
1.75
1.61
1.2
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
27
163
1.63
1.61
2.9
2.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
27
163
1.63
1.61
2.9
2.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
39
560
0.68
1.60
1.0
1.1
u/ml
1.9
3.3
0.94
15
206
(3021788) Differential panel - Synovial fluid
107
1318
0.79
1.59
1.5
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
43
290
1.46
1.59
1.3
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
98
755
1.28
1.58
1.1
1.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
109
851
1.26
1.58
2.4
2.3
mmol/l
104.5
105.6
1.20
109
846
(3041354) Potassium [Moles/volume] in Venous blood
109
851
1.26
1.58
2.4
2.3
mmol/l
4.0
4.0
0.49
109
846
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
8
168
0.47
1.58
1.3
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
230
2630
0.85
1.57
1.6
1.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
165
1941
0.83
1.57
1.4
1.3
u/ml
13.5
4.8
0.32
18
231
(3033705) Calcium.ionized [Moles/volume] in Venous blood
108
843
1.26
1.57
2.4
2.3
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
34
499
0.67
1.57
1.0
1.1
u/ml
0.3
0.4
—
6
109
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
87
1097
0.78
1.57
2.0
1.7
nmol/l
1.0
0.8
1.67
70
899
(3005988) Vibrio sp identified in Specimen by Organism specific culture
105
817
1.27
1.57
1.3
1.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
218
1828
1.18
1.56
2.8
1.6
ratio
1.3
1.5
0.43
17
156
(3000093) Morphology [Interpretation] in Blood Narrative
61
440
1.37
1.56
1.1
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
40
267
1.47
1.56
1.3
1.3
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
7
26
2.65
1.54
1.1
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
43
292
1.45
1.54
1.3
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
271
2315
1.16
1.54
4.4
3.3
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
20
113
1.74
1.51
1.0
1.1
%
131.4
112.8
1.46
20
108
(3024522) Salmonella sp identified in Specimen by Organism specific culture
106
830
1.26
1.51
1.3
1.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
11
50
2.16
1.50
3.0
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
733
6646
1.09
1.50
1.5
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
47
643
0.72
1.49
1.3
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
94
727
1.27
1.49
1.1
1.2
u/ml
279.9
288.8
0.11
53
473
(3013512) EKG study
2051
19307
1.06
1.48
4.2
4.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
200
1675
1.18
1.47
3.0
3.4
nmol/l
0.8
0.8
1.65
157
1329
(40762365) Oxygen content in Arterial blood by calculation
13
64
2.00
1.47
1.8
2.1
ml/dl
14.7
15.2
0.26
13
55
(3008536) Aspergillus sp Ab [Presence] in Serum
14
71
1.94
1.47
1.1
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1350
12549
1.07
1.46
3.7
3.8
ng/l
111.8
297.8
5.93
1073
9705
(3000012) Reticulocyte production index
47
329
1.41
1.45
1.5
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
24
145
1.63
1.44
1.1
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
67
862
0.76
1.43
1.1
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
169
1964
0.84
1.43
1.4
1.3
u/ml
14.8
4.8
0.90
32
355
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
101
795
1.25
1.40
1.1
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
160
1863
0.84
1.39
1.4
1.6
iu/ml
0.1
1.4
0.54
48
395
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
28
415
0.66
1.39
1.4
1.5
u/l
7.1
7.0
0.01
11
194
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
40
2.21
1.37
1.9
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
61
452
1.33
1.35
1.1
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
107
853
1.24
1.34
1.3
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
55
402
1.35
1.33
1.3
2.1
%
9.1
10.8
2.47
55
402
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
15
255
0.58
1.33
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
5498
54795
0.95
1.31
23.5
14.2
%
37.0
38.6
29.55
3611
36435
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
73
914
0.78
1.30
1.5
1.6
%
57.8
55.8
0.19
45
571
(3011985) Renin [Units/volume] in Plasma
108
867
1.23
1.28
1.3
1.3
mu/l
70.8
55.6
0.21
95
769
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
38
522
0.71
1.28
1.1
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
11
202
0.53
1.28
1.2
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
97
770
1.24
1.28
1.1
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
98
779
1.24
1.27
1.0
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
6
24
2.46
1.27
1.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
38
521
0.72
1.27
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
38
521
0.72
1.27
1.1
1.2
—
—
—
0
0
(44813793)
36
498
0.71
1.26
1.1
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
280
3098
0.88
1.26
1.1
1.1
titre
125.0
173.2
—
6
67
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
38
520
0.72
1.25
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
38
520
0.72
1.25
1.1
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
27
175
1.52
1.25
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
38
519
0.72
1.24
1.1
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
17
273
0.61
1.23
1.2
1.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
31
208
1.47
1.23
3.5
4.2
mg/l
85.8
63.3
0.55
24
135
(3022689) Creatine [Moles/volume] in Urine
11
198
0.55
1.21
1.5
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
66
827
0.78
1.20
1.3
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
35
481
0.71
1.20
1.2
1.2
u/ml
1.3
1.2
0.04
17
227
(40768443) Skin Pathology biopsy report
310
2729
1.12
1.18
1.3
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
13
221
0.58
1.18
1.1
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
47
614
0.75
1.17
1.4
1.6
u/ml
24.1
23.0
—
8
142
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
157
1319
1.17
1.17
2.3
2.3
ug/min
115.7
60.9
0.51
84
711
(3003338) MCHC [Mass/volume]
5305
51373
1.05
1.16
30.9
16.9
g/l
329.0
330.3
24.70
5249
50974
(3047189) Immunofixation for 24 hour Urine
24
155
1.52
1.14
2.5
1.3
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
48
621
0.76
1.13
1.1
1.2
nmol/l
358.7
349.3
0.10
38
505
(44806420)
30
204
1.45
1.13
2.8
2.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
162
1370
1.17
1.12
3.0
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
33
229
1.42
1.12
1.3
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
33
229
1.42
1.12
1.3
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
23
148
1.53
1.12
1.7
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
138
1588
0.85
1.11
1.3
1.3
u/ml
48.1
48.4
0.01
18
186
(3004588) Protein electrophoresis panel - Serum or Plasma
473
4276
1.09
1.09
2.0
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
44
573
0.75
1.09
1.2
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
80
967
0.81
1.09
1.5
1.3
u/ml
55.5
64.4
—
10
79
(3021387) Prolactin [Units/volume] in Serum or Plasma
102
1203
0.83
1.09
1.7
1.7
mu/l
364.6
315.6
0.78
92
1067
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
6797
66318
1.08
1.08
15.7
9.4
u/l
23.5
23.1
1.03
6602
63198
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
12
65
1.82
1.08
1.0
1.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
160
1360
1.16
1.06
1.3
1.3
miu/ml
276.6
215.2
0.93
58
649
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
236
2061
1.13
1.05
4.6
3.5
mmol/l
24.8
25.3
1.43
215
1853
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
48
359
1.32
1.05
1.3
1.4
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
46
591
0.76
1.05
1.2
1.1
—
31.2
—
0
6
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
92
746
1.21
1.04
1.1
1.1
%
131.2
122.6
1.17
78
661
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
32
226
1.39
1.01
1.7
2.3
e6/l
586.0
782.0
—
10
119
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
122
1020
1.18
1.00
1.2
1.2
nmol/l
0.6
2.2
0.71
117
970
(3036603) Volume of Urine
48
362
1.30
1.00
1.4
1.4
ml
1658.2
1928.7
0.53
13
94
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
35
464
0.74
1.00
1.2
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
438
4665
0.92
1.00
1.2
1.2
iu/ml
123.9
144.8
0.63
173
1831
(1001926) Buprenorphine [Presence] in Urine by Screen method
62
761
0.80
0.99
1.2
1.6
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
12
67
1.76
0.99
1.3
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
376
4030
0.91
0.99
2.4
2.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
763
7064
1.07
0.98
1.4
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
773
8051
0.94
0.98
1.8
2.0
ug/g
119.5
123.3
0.12
595
6080
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
18
268
0.66
0.98
1.4
1.6
ug/l
0.6
0.4
0.46
12
163
(4034850)
258
2278
1.12
0.98
12.0
9.9
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
29
0.00
0.97
0.0
1.0
—
2.8
—
0
21
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
55
682
0.79
0.97
1.4
1.4
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
98
807
1.20
0.96
1.1
1.2
pmol/l
412.4
283.5
0.46
78
613
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
14
219
0.63
0.95
1.1
1.1
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
16
99
1.59
0.94
1.1
1.4
u/l
15.8
37.5
0.74
16
90
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
113
948
1.17
0.91
1.2
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
21
298
0.69
0.91
1.1
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
164
1830
0.88
0.91
1.4
1.4
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
60
730
0.81
0.91
1.3
1.6
—
24.3
—
0
36
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
612
5641
1.07
0.91
3.4
3.1
ng/l
87.2
83.3
0.58
505
4661
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2047
20736
0.96
0.91
2.2
2.1
u/l
177.0
175.4
0.03
1918
19145
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
18
116
1.53
0.90
1.2
1.1
pmol/l
1.8
3.9
—
5
13
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
98
814
1.19
0.89
1.1
1.2
u/ml
3.4
4.2
0.18
30
280
(44816559) Phosphatidylethanol [Mass/volume] in Blood
70
834
0.82
0.88
1.2
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
36
463
0.76
0.86
1.2
1.3
mmol/l
13.4
11.7
—
5
93
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
251
2232
1.11
0.86
1.5
1.6
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
64
512
1.23
0.86
1.5
1.7
umol/l
7.8
7.4
0.08
47
367
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
95
791
1.18
0.85
1.1
1.2
u/ml
2.7
4.1
1.53
43
328
(3007566) Smooth muscle Ab [Titer] in Serum
185
1618
1.13
0.85
1.2
1.2
titre
72.1
179.0
1.49
14
124
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
44
337
1.28
0.85
1.1
1.1
ratio
1.1
1.1
0.19
15
125
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
51
626
0.80
0.85
1.3
1.2
u/ml
18.3
42.8
—
7
57
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
65
775
0.82
0.83
1.0
1.1
u/ml
2.8
3.3
0.20
28
301
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
19
269
0.69
0.83
1.4
1.4
pmol/l
14.6
15.9
0.87
13
222
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
6
31
1.90
0.83
1.3
1.2
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
47
367
1.26
0.80
1.7
1.7
umol/l
63.0
63.9
—
6
24
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
560
5845
0.94
0.79
2.6
2.9
ng/l
205.1
191.1
0.33
511
5328
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
38
289
1.29
0.79
1.4
1.7
nmol/l
8.0
4.6
0.23
32
232
(3034770) Mitochondria Ab [Titer] in Serum
186
1638
1.12
0.78
1.2
1.2
titre
687.1
944.3
—
7
74
(3016018) Differential panel - Cerebral spinal fluid
48
586
0.80
0.78
1.3
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
922
9477
0.95
0.78
1.2
1.2
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
11
65
1.66
0.78
2.1
1.5
pmol/l
53.7
51.0
0.04
11
53
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
25
179
1.37
0.77
1.0
1.1
%
96.5
95.6
—
6
85
(4306422)
92
773
1.17
0.77
1.1
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
35
265
1.30
0.76
1.3
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
50
605
0.81
0.76
1.0
1.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
5
23
2.14
0.75
1.6
1.7
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
27
352
0.75
0.74
1.1
1.1
u/ml
3.7
7.1
—
5
48
(3045414) Leukocytes [Presence] in Urine
348
3173
1.08
0.73
2.2
2.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
23
164
1.38
0.73
1.3
1.2
—
—
—
0
0
(4268621)
66
542
1.20
0.72
2.2
2.2
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
31
233
1.31
0.71
1.1
1.0
%
83.7
95.5
1.34
20
175
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
49
589
0.82
0.71
1.3
1.2
u/ml
9.4
3.9
—
5
38
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
7
40
1.72
0.70
1.6
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
48
575
0.82
0.68
1.1
1.1
—
4.0
—
0
5
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
15
212
0.69
0.68
1.3
1.4
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
16
223
0.70
0.67
1.1
1.5
mmol/l
8.1
8.0
—
9
128
(3010144) Erythrocytes [#/volume] in Synovial fluid
78
656
1.17
0.67
1.4
1.4
e6/l
22271.0
141085.8
3.98
55
440
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
11
165
0.65
0.67
1.2
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
47
561
0.82
0.65
1.1
1.1
—
85.9
—
0
7
(3045716) Anion gap in Serum or Plasma
35
272
1.27
0.65
2.5
2.3
mmol/l
10.1
8.9
1.02
26
201
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
25
186
1.32
0.63
1.0
1.1
%
88.2
91.8
—
6
86
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
37
451
0.81
0.63
1.1
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
19
253
0.74
0.62
1.1
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
66
759
0.85
0.62
1.2
1.3
mmol/l
8.4
7.5
0.97
48
546
(3050794) Legionella sp Ab [Presence] in Serum
8
48
1.64
0.62
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
100
1115
0.88
0.62
1.5
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2789
26895
1.03
0.62
2.7
2.8
ug/l
161.9
96.8
29.03
2554
24541
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
10
62
1.59
0.61
1.4
1.2
pmol/l
12.3
15.0
—
10
56
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
104
902
1.13
0.61
1.2
1.2
nmol/l
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
21
0.00
0.60
0.0
1.5
—
264.8
—
0
21
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
14
95
1.45
0.59
1.1
1.4
%
37.8
46.4
—
5
51
(3010937) Rubella virus Ab [Presence] in Serum
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
30
370
0.80
0.58
1.1
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
78
879
0.87
0.57
1.3
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
16
215
0.73
0.57
1.3
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
85
0.58
0.56
1.0
1.1
umol/24h
1.6
1.5
—
5
85
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
86
0.57
0.56
1.0
2.0
umol/l
18.1
17.7
—
5
86
(3028300) Cannabinoids [Presence] in Urine
87
969
0.88
0.55
1.3
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
48
558
0.84
0.53
1.6
1.7
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
51
424
1.18
0.53
2.2
2.3
ml
573.2
623.8
0.49
31
301
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
57
652
0.86
0.53
1.4
1.5
%
32.4
33.5
0.08
39
380
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1590
15242
1.03
0.52
1.6
1.7
pmol/l
25694939.8
33415191.4
0.24
1296
12285
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
25
310
0.79
0.52
1.4
1.7
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
40
326
1.21
0.52
1.2
1.1
u/l
89.3
74.6
0.96
25
243
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
40
326
1.21
0.52
1.2
1.1
u/l
21.8
20.1
0.10
24
236
(3027008) Opiates [Presence] in Urine
87
964
0.89
0.52
1.3
1.6
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
39
1.51
0.52
1.5
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
9
63
1.40
0.51
1.0
1.0
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
14
188
0.73
0.51
1.0
1.1
umol/24h
0.6
0.6
—
5
84
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
65
555
1.15
0.50
1.1
1.1
%
97.4
93.6
0.48
60
516
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
28
221
1.25
0.49
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
46
531
0.85
0.49
1.4
1.5
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
12
164
0.72
0.48
1.7
1.4
ng/l
149.0
89.9
0.64
12
164
(4024509)
77
855
0.88
0.48
1.7
1.7
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
164
1748
0.92
0.48
1.7
1.6
e6/l
16087.6
12923.4
0.35
120
1255
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
7
46
1.50
0.47
1.3
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
88
965
0.89
0.46
1.3
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
35
411
0.84
0.46
1.1
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
31
251
1.21
0.44
3.3
4.1
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
16
119
1.32
0.43
5.7
5.3
%
70.7
68.2
0.12
11
93
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
28
334
0.82
0.43
2.2
1.8
—
—
—
0
0
(3012565) Volume of 24 hour Urine
32
261
1.21
0.43
2.1
1.8
ml
1778.5
1839.5
0.14
26
232
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
109
975
1.10
0.42
1.5
1.6
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
91
0.65
0.42
33.7
10.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
91
0.65
0.42
2.0
1.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
32
1.54
0.41
1.2
1.3
—
—
—
0
0
(3025315) Body weight
5
32
1.54
0.41
5.0
4.9
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
24
289
0.82
0.41
1.0
1.0
u/ml
0.7
2.3
—
9
87
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
5
33
1.49
0.40
1.0
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
21
256
0.81
0.40
3.0
2.0
umol/l
173.1
127.6
0.19
11
140
(40762887) Creatinine [Moles/volume] in Blood
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
7
100
0.69
0.39
1.3
1.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
57
494
1.13
0.39
1.9
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
173
1587
1.07
0.39
2.2
1.5
g/l
0.0
0.0
0.00
155
1445
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
35
1.40
0.38
3.8
1.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
9
65
1.36
0.38
1.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
18
140
1.26
0.37
1.1
1.3
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
36
1.36
0.37
1.0
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
36
1.36
0.37
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
306
3156
0.95
0.37
1.7
1.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
43
485
0.87
0.37
1.1
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
14
177
0.78
0.36
1.4
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
15
114
1.29
0.36
1.1
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
25
295
0.83
0.36
2.4
2.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
17
132
1.27
0.36
1.4
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
17
132
1.27
0.36
1.2
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
76
0.65
0.35
1.6
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
175
1614
1.07
0.35
2.2
1.5
g/l
0.0
0.0
0.50
155
1451
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
11
143
0.76
0.35
1.2
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
88
946
0.91
0.35
1.3
1.6
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
43
1.37
0.34
1.0
2.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
12
89
1.33
0.34
1.1
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
105
951
1.09
0.34
1.6
1.7
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
10
72
1.37
0.33
1.1
1.2
ng/l
43.1
87.6
—
5
49
(3052592) Norovirus Ag [Presence] in Stool
15
116
1.27
0.33
1.6
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
56
614
0.90
0.33
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
56
614
0.90
0.33
1.1
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
17
206
0.81
0.33
2.6
1.7
ug/l
9.3
8.8
0.19
17
206
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
19
152
1.23
0.32
1.9
2.5
mmol/l
6.5
7.3
0.76
13
97
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
116
1226
0.93
0.32
1.2
1.3
—
78.3
—
0
24
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
28
322
0.85
0.32
1.3
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
61
664
0.90
0.32
1.6
2.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
75
807
0.91
0.31
1.2
1.2
u/l
66.8
28.7
0.42
63
690
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
14
108
1.27
0.31
1.5
1.6
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
24
279
0.84
0.31
1.1
1.1
u/l
1.1
1.1
0.31
11
129
(3023511) Choriogonadotropin [Units/volume] in Urine
61
662
0.90
0.31
1.3
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
99
0.69
0.30
1.1
1.3
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
12
150
0.79
0.30
1.2
1.1
u/ml
0.4
1.3
—
7
73
(3024980) IgG subclass 4 [Mass/volume] in Serum
84
896
0.92
0.30
1.3
1.5
g/l
0.7
0.7
0.05
63
660
(3020650) Glucose [Presence] in Urine
17
136
1.23
0.29
1.1
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
10
128
0.77
0.29
1.5
2.4
—
—
—
0
0
(3019225) pH of Specimen
685
6904
0.97
0.29
4.2
3.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
62
669
0.91
0.28
1.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
8
108
0.73
0.28
1.9
4.7
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
11
138
0.78
0.28
1.4
1.2
mu/l
83.8
55.7
—
6
99
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
71
760
0.92
0.28
1.1
1.1
iu/ml
1.3
15288.4
0.55
13
156
(3000034) Microalbumin [Mass/volume] in Urine
54
586
0.90
0.28
3.3
3.0
mg/l
88.7
28.3
0.84
42
387
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
73
659
1.09
0.27
1.2
1.1
g/l
1.6
1.5
1.84
66
582
(4133840)
9
117
0.76
0.27
1.1
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
137
1269
1.06
0.27
2.2
2.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
8
64
1.23
0.27
2.3
2.0
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
24
274
0.86
0.26
1.1
1.0
u/ml
0.7
0.7
—
6
65
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
65
1.21
0.26
1.1
1.4
—
—
—
0
0
(4015189)
15
179
0.82
0.26
1.7
2.6
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
66
1.19
0.26
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
386
3672
1.03
0.26
5.0
3.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
97
1020
0.93
0.26
1.2
1.3
—
—
—
0
0
(4027681)
33
286
1.13
0.25
1.2
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
35
305
1.13
0.25
1.1
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
17
139
1.20
0.25
5.8
5.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
49
530
0.91
0.25
3.4
3.5
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
20
230
0.85
0.24
1.1
1.1
ng/l
35.1
204.3
—
7
52
(3034426) Prothrombin time (PT)
20
167
1.18
0.24
1.1
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
38
416
0.90
0.24
1.1
1.0
mg/l
310.7
299.5
0.50
31
368
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
139
1295
1.06
0.24
1.1
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
33
364
0.89
0.24
2.3
2.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
20
229
0.86
0.23
1.0
1.1
miu/ml
2312.5
1636.0
1.41
20
229
(3002619) Bacteria identified in Specimen by Culture
16
131
1.20
0.23
1.1
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
29
251
1.14
0.23
1.3
1.3
nmol/l
138.4
131.8
0.42
29
251
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
35
307
1.12
0.23
1.1
1.1
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
5
37
1.33
0.23
1.0
1.0
u/l
31.0
46.1
—
5
29
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
199
1874
1.04
0.23
1.7
1.9
iu/l
5.1
9.1
0.41
74
674
(3025018) Bordetella pertussis Ab [Titer] in Serum
33
363
0.89
0.23
1.2
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
162
1668
0.95
0.23
2.5
2.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
28
311
0.88
0.22
1.0
1.1
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
18
207
0.85
0.22
10.2
10.7
nmol/l
793.5
833.2
0.18
18
198
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
200
2047
0.96
0.22
1.5
1.7
titre
630.0
302.7
—
6
119
(3024263) Appearance of Synovial fluid
30
331
0.89
0.22
1.7
1.6
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
5
40
1.23
0.22
1.6
1.1
u/l
4.2
14.0
—
5
40
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
5
40
1.23
0.22
1.4
2.0
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
69
630
1.08
0.22
1.3
1.4
mosm/kgh2o
273.8
273.6
0.01
47
464
(3014271) Vancomycin [Susceptibility]
35
382
0.90
0.22
2.7
3.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
27
234
1.13
0.22
1.2
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
27
234
1.13
0.22
1.2
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
27
234
1.13
0.22
1.2
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
23
197
1.15
0.21
1.1
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3026926) Nortriptyline [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
175.7
—
0
6
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
111
1151
0.95
0.21
1.2
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
100
0.79
0.21
1.1
1.1
—
—
—
0
0
(4062490)
55
585
0.92
0.21
1.2
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
27
235
1.13
0.21
1.2
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
187
1765
1.04
0.20
1.4
1.5
—
—
—
0
0
(3021367) Citalopram [Moles/volume] in Serum or Plasma
0
13
0.00
0.20
0.0
1.5
—
119.4
—
0
5
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
13
0.00
0.20
0.0
1.1
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
13
0.00
0.20
0.0
1.1
—
1837.7
—
0
13
(3000285) Sodium [Moles/volume] in Blood
13
106
1.21
0.20
1.1
1.3
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
0.0
—
0
6
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
117
1209
0.95
0.20
1.4
1.4
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
9
113
0.78
0.20
1.1
1.2
—
101.5
—
0
8
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
30
328
0.90
0.20
1.2
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
121
1132
1.05
0.19
1.1
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
27
297
0.89
0.19
1.1
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
10
120
0.82
0.19
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
75
692
1.07
0.19
2.3
2.6
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
183
1731
1.04
0.19
2.4
1.5
g/l
0.0
0.0
0.48
163
1561
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
11
89
1.21
0.18
1.1
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
7
58
1.19
0.18
2.3
2.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
141
1444
0.96
0.18
1.2
1.3
mg/l
568.2
516.7
0.32
136
1353
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
7
59
1.17
0.17
1.6
1.9
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
75
695
1.06
0.17
1.2
1.1
u/l
55.5
58.8
0.35
57
466
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
5
66
0.74
0.17
1.2
1.3
pmol/l
25.1
10.6
—
5
59
(3011897) Casein IgE Ab [Units/volume] in Serum
5
69
0.71
0.16
1.2
1.1
—
4.7
—
0
13
(3017732) Neutrophils [#/volume] in Blood
451
4341
1.02
0.16
5.0
2.8
e9/l
4.2
4.0
0.64
339
3156
(3006462) Nitrate [Presence] in Urine
31
334
0.91
0.16
3.5
3.9
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
68
1.16
0.16
1.3
1.7
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
38
405
0.92
0.16
1.1
1.1
iu/ml
6.8
10.6
0.78
12
74
(3022621) pH of Urine by Test strip
473
4738
0.98
0.16
3.2
3.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
209
1992
1.03
0.16
2.4
1.5
g/l
0.7
0.4
0.84
172
1655
(3013637) Mi-2 Ab [Presence] in Serum
15
169
0.87
0.15
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
15
169
0.87
0.15
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
15
169
0.87
0.15
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
15
169
0.87
0.15
1.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
78
0.76
0.15
1.0
1.1
—
—
—
0
0
(44806071)
9
78
1.13
0.15
1.0
1.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
272
2606
1.03
0.15
1.4
1.6
u/ml
28.3
13.9
—
7
57
(3006922) Hepatitis E virus Ab [Presence] in Serum
37
336
1.08
0.15
1.1
1.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
35
372
0.92
0.14
1.0
1.1
mg/l
295.4
247.2
0.51
30
330
(3035320) C reactive protein [Mass/volume] in Body fluid
44
463
0.93
0.14
1.9
2.5
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
7
86
0.80
0.14
1.0
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
7
86
0.80
0.14
1.0
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
87
0.79
0.14
1.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
14
120
1.15
0.13
1.1
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
19
167
1.12
0.13
1.7
1.7
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
44
461
0.94
0.13
1.1
1.2
titre
83.8
166.1
—
8
85
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
59
550
1.05
0.12
1.3
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
212
2033
1.03
0.12
1.4
1.4
ug/g
261.3
294.8
1.69
119
1158
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
38
350
1.07
0.11
1.9
2.1
u/field
2.2
2.9
0.30
29
219
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
233
2240
1.02
0.11
2.2
1.4
g/l
3.3
3.1
1.43
178
1686
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
209
2008
1.02
0.11
1.6
1.7
g/l
1.2
1.2
0.54
202
1886
(3044927) Protein electrophoresis panel - Urine
68
697
0.96
0.10
1.2
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
22
235
0.92
0.10
1.0
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
126
1273
0.97
0.10
1.2
1.2
mmol/l
3.7
3.8
0.06
120
1190
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
33
345
0.94
0.10
1.2
1.2
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
43
1.14
0.10
1.0
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
46
1.07
0.09
1.2
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
49
459
1.05
0.09
1.9
1.7
—
—
—
0
0
(3016750) Collection duration of Urine
33
305
1.06
0.09
2.2
2.2
min
503.1
506.9
0.10
22
236
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
233
2247
1.02
0.09
2.0
1.4
g/l
9.8
10.1
0.49
188
1824
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
17
152
1.10
0.09
1.0
1.1
—
—
—
0
0
(4212803)
5
48
1.02
0.09
1.0
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
33
306
1.06
0.08
1.9
2.2
u/ml
959.9
832.2
0.25
33
299
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
57
1.03
0.08
1.3
1.5
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
15
134
1.10
0.08
1.1
1.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
7
63
1.09
0.08
1.3
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
11
96
1.13
0.08
4.9
7.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
2047
20200
0.99
0.08
4.0
3.8
mg/mmol
12.7
7.5
4.38
1239
11404
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
89
900
0.97
0.08
2.4
2.0
mg/l
29.0
24.2
0.33
28
229
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
69
0.85
0.07
1.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
6
71
0.83
0.07
1.0
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
73
0.81
0.07
2.3
2.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
17
181
0.92
0.07
1.1
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
19
173
1.08
0.07
1.2
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
19
173
1.08
0.07
1.2
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
17
154
1.08
0.07
1.0
1.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
7
82
0.84
0.07
1.0
1.1
mg/g
11.8
7.0
—
7
74
(3020491) Glucose [Moles/volume] in Blood
46
434
1.04
0.07
1.6
2.0
mmol/l
7.6
6.9
0.81
32
294
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
63
599
1.03
0.07
2.7
2.4
u/field
3.3
2.9
0.14
24
206
(3038071) Oxygen [Partial pressure] in Mixed venous blood
9
87
1.02
0.06
4.8
7.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
8
91
0.86
0.06
1.0
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
14
126
1.09
0.06
1.2
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
9
103
0.86
0.06
1.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
139
0.92
0.06
1.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
94
944
0.98
0.05
1.1
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
80
768
1.02
0.05
1.2
1.3
—
33.3
—
0
8
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
126
1259
0.98
0.05
1.4
1.4
e6/l
358.9
1343.6
2.53
105
1050
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
195
1892
1.01
0.05
2.2
1.4
g/l
36.8
37.5
0.93
166
1551
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
204
1981
1.01
0.05
1.6
1.7
g/l
0.2
0.2
0.53
194
1861
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
13
118
1.08
0.04
1.2
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
246
2393
1.01
0.04
2.2
1.4
g/l
3.8
3.7
0.39
178
1650
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
246
2393
1.01
0.04
2.2
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
126
1257
0.98
0.04
1.3
1.4
e6/l
12.4
27.6
0.96
97
995
(4146454)
76
731
1.02
0.04
2.7
2.6
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
12
109
1.08
0.04
1.5
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
11
117
0.92
0.04
1.3
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
31
294
1.04
0.03
1.6
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
246
2398
1.01
0.03
2.2
1.4
g/l
7.7
7.6
0.35
180
1711
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
18
186
0.95
0.03
1.2
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
2018
19790
1.00
0.03
3.1
3.0
mmol/l
6.2
6.2
0.23
1679
16448
(3036071) Salmonella sp Ab [Titer] in Serum
15
156
0.94
0.03
1.2
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
19
178
1.05
0.03
1.3
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
48
461
1.02
0.03
1.3
1.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
37
354
1.03
0.02
1.1
1.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
164
1624
0.99
0.02
1.9
2.1
mg/l
10.8
11.1
0.30
152
1480
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
19
179
1.04
0.02
1.2
1.4
%
38.6
35.5
0.12
11
126
(3027135) IgG subclass 1 [Mass/volume] in Serum
61
590
1.02
0.02
1.2
1.5
g/l
6.6
6.8
0.16
44
408
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
39
375
1.02
0.02
1.0
1.0
nmol/l
40.7
5.9
—
8
76
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
260
2567
1.00
0.01
2.0
2.0
u/l
38.9
40.0
0.41
228
2246
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
19
194
0.96
0.01
1.5
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1953
19171
1.00
0.01
3.2
3.1
mg/l
554.2
406.2
0.57
1192
10681
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
362
3568
1.00
0.01
1.7
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
32
321
0.98
0.01
1.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
17
161
1.04
0.01
2.4
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
153
0.96
0.00
1.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
14
134
1.03
0.00
1.2
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
15
144
1.02
0.00
1.0
1.1
—
—
—
0
0
(4198724)
12
119
0.99
0.00
1.3
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
31
305
1.00
0.00
1.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
14
137
1.00
0.00
1.4
1.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
15
147
1.00
0.00
1.3
1.6
—
—
—
0
0
(4211845)
36
359
0.99
0.00
3.3
3.8
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
153
1.03
0.00
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
16
153
1.03
0.00
1.0
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
23
226
1.00
0.00
1.2
1.3
g/l
36.1
38.7
0.34
14
119
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
10
95
1.03
0.00
3.4
3.0
u/field
0.7
0.8
—
10
95
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
15
148
1.00
0.00
1.1
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
13
131
0.98
0.00
2.2
1.8
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
27
270
0.98
0.00
1.2
1.1
—
8.5
—
0
22
(3051593) INR in Capillary blood by Coagulation assay
32
311
1.01
0.00
14.0
10.7
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
60
590
1.00
0.00
1.2
1.5
g/l
2.7
2.9
0.19
42
406
(3024139) IgG subclass 3 [Mass/volume] in Serum
60
590
1.00
0.00
1.2
1.5
g/l
0.5
0.4
0.82
43
408
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
13
126
1.01
0.00
1.2
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
6
62
0.95
0.00
2.2
2.4
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
1.1
—
0
8
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
76
0.90
0.00
1.0
1.1
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
30.7
—
0
9
(3025504) Homovanillate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
68
1.01
0.00
3.1
7.2
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
83.2
—
0
8
(3036005) Urine sediment comments by Light microscopy Narrative
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
60
0.98
0.00
1.0
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
9
89
0.99
0.00
1.1
1.0
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
4.6
—
1.8
—
0
8
(3007919) Fasciola sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042628) Porphyrins [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
6
58
1.02
0.00
1.3
1.6
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
9
96
0.92
0.00
1.4
1.4
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
110.7
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_FEMALE_GENITAL_EXALLC – malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).